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ABSTRAC'l'
The clearance mechanism of C-reactive proteins (CRP)
....as examined in this study .~ binding assays us i ng
isolated r at hepatocytes ....ere followed by c learance studies
~ and using perfused rat liver .
It ....as shown that r a t asialo CRP was rapidly cleared
from the circulation (half-life about 4 min ) , whereas rat
and rabbit CRP remained in the circulation f or muc h longer
periods of tilne (ha lf- li f e 7 .S h for rat CRP) . The clearance
of rat asialo CRP was shown to be mediated through the
hepatic asialoglycoprotein receptor, a nd this clearance was
not affected by the phosphorylcholine binding domain of rat
asialo CRP. Results of the clearance studies also suggested
that, in addition t o liver , lungs might also be involved in
the clearance o f CRP.
It was observed that l ar ge amounts of r at asia lo CRP,
rat CRP and rabbit CRP bound to isolated rat hepatocytes,
and the binding was shown to be mediated predomi nantly
t hrough the phesphorylchollne binding domain of t h es e
proteins . In addition, rat asble CRP was sho....n to bind t o
the hepatic asialoqlycoprotein receptor on the hepatocytes,
despite the avid phesphorylchol!ne binding domain-mediated
binding of this protein. I t ....as demonstra.ted that the
binding of l arg e amounts of rat asialo CRP, rat CRP and
11
rabbit CRP to the hepatocytes through t h e phosphorylcholine
binding domain resul ted from a disruption of the hepatocyte
su rface .
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Chap ter 1. INTRODUCTION
C- r ea ctive prot e i n s (CRP) are pre s ent in a wide r an ge
of species , from horseshoe cra b (I,i mulus pgl yph emus ) to
huma n being . CRP derives its n ame f rom a phosph orylc hollne-
mediated reactiv ity wi th t he C-po lysaccharide of the pneumo -
cocca l ce l l wall (Abernethy a nd Ave r y , 1941 ; Ma c Leod a nd
Avery, 194 1 ; Volanakis and Kap lan, 1971) . These proteins
have two c ommon c harac teristics t ha t have been co nserved
throughout evolution : i) a pe n t amer i c disc-like configu-
r at i on (Osmand et al., 1977) (wi th t he only exception of
ho rseshoe crab CRP, which has a hexa go na l r i ng-shap ed
structure (Robey and Li u , 19811) , and il l a ca lcium
dependent binding to t he phosphorylchollne ligand (Volanakis
and Kaplan , 1971) . In add ition , t he y s ha re ex tensive amino
a c i d sequence homology (Oliveira et a!., 1979; Wang e t a I.,
19 82 ; Pepys et a l ., 1984 ; Nguy en et al ., 1986a ). Based on
thei r glyc o s yla t i on s tatus , CRP can be divided into t wo
cat egories: al No n- gly cos yl a t e d CRP, such as human an d
rabbit CRP; an d b) Glycosylated CRP, such as r a t CRP. CRP
ar e synt hes ized in the liver by hepatocyte s (Kushner e t al. ,
1980 ; Col lins et a!. , 1984) . However, their c l earance
pathway is not known.
I n t he 1970 1s , Ashwe ll d i s covered t ha t , a fter t h e
removal o f t e rmi nal s ial ic ac ids , most mammalian circulatory
glyoo-prote i ns a re t aken up by the l i ver via the hep a tic
asialoglycoprotein receptor (Morell et aI., 1971 : Ashwell
and Harford, 19 82 : Ashwel l, 1984) . I n t h e ca s e of the CRP
family , s ince acme are glycosy lated while others are no n -
glycosylated, it is appr o priat e t o study if Ashwell' s
clearance pathway i s app licable to glycosy lated CRP and it
glycosylated and non-glycosylated CRP are c leared through a
c oemon mecha n i s m. In add ition, it is important to exami ne i f
the highly conserved phosphorylcholine binding do main of CRP
would affect the b inding of asia lo CRP to the hepatic
asia loglycoprotein receptor , and if this bind i ng would
affect their sUbsequent clearance through Ashwell ' 5 pathway .
As a necessary background for this thesis, an OVQrviQW
o n C-reactive proteins and an outline of the structure a nd
clearance pa t hways of glycoproteins have been provided .
section I . QVERVnW ON C-REACTI YIj 'ROIIINS
A . DIScoyERY AND DEFINITION or C-RUCTIVJj PRQ'l'!XIlB
I n 19 30 , Til l et t and Franc i s ( 193 0) observed t hat sera
obtainod from pa t i e nt s during a cute febrile illnesses
precipitated with an extract of a pneumococcus, which was
first des ignated as Fraction C and subsequently as c-
po lysaccharide (CPS) . The substance responsible tor t his
reactivity was t e rmed c -precipitin . I t was l a t er p r oven to
be a protein no t n orma l l y present in the blood an d was
designated as C- reactive protein (CRP) (Abe r net hy and Ave ry,
194 1) •
SUbsequently , it was demons trated t hat the reaction of
CRP towards CPS is directed t o t he ph o s phorylchol ine residue
on CPS (Volanakis a nd Kapl an , 19 71 ) . This bindi ng
specificity of human CRP ha s been uti lized t o defi ne CRP
homol ogues; i n other species . Protein:!:: from t he sera of other
species which e xhibit a similar ca 2' - dependent binding to
immobi lize d CPs , phosphor ylcholine, o r pho s phorylcholin e
derivatives are a lso d e s i gnated as CRP . These prote i ns
c losely r e s embl e human CRP in molecular ap pearance, sub u n i t
composition and amino acid s equ e nce (Bach et; aL, , 1971 :
Pepys ee a1., 197 8a ) .
Some members of the CRP family h a v e been refe rred t o by
other names. For example, l i mulu s CRP had been known a s
l i mul i n befor e i t was cha ract erized as a me mber of the CRP
family (Robey and Li u 1981) . When rat CRP was first isolated
by Nagpurkar and Mookerjea, it was t ermed rat ph osphcryl-
cho l i ne bind ing protein (PCBP) on t he ba sis o f its p r operty
of binding t o phosphoryl chol1ne (Nagpur ka r and Mookerjea ,
1981) . It was s ubs e quent ly sh own to be i de nt i c a l to r at CRP
independently isolatlid by Pontet a t al. ( 1981 ) and d e Beer
et a1. (1982a) . In t hi s thes i s , the term rat CRP i s us ed ,
i nstead of rat PCBP.
B. pISTRIBUTION OP CSP
Si nce t he discovery of CRP in humans , CRP has bee n
fo und i n a variety of species (Table 1 ) . CRP has been
conserved throughout the ev ol u t i on proces s, from horseshoe
cra b s to human be ings. The mol ec u l a r app earance, subunit
composition , ami n o ac id s equ e nce an d binding s pe c i ficity of
CRP have been conserved during this process .
C. ISOLATION AND PROPERTIES 0' CRP
1). Isolation of eRP
CRP was f i r s t isolated i n a crystalline form from a
lipoprotein - rich traction of human s e rum by pre c ipitating
with CPS, f ollowed by delipidation and s a l t fractionation
(Mccarty, 1947 ; Wood e t a1., 1955 ) . More recent methods of
purification involve affinity chromatograp hy techniques
using immobilized CPS, phosphorylcholine or phosphoryl-
chol ine de r ivat ives (Os man d e t a1. , 19 75 ; You ng and
Table 1 . DI8TR.IBO'I'ION or C-UACTIVB PROTBINS
Name Sub u ni t s Gl y c o s ylat i on MW
Human CRP! No 117 .5 kd
Monkey CRP»
Bov i n e CRP~ No 15 0 kd
Goat CRP! Yes 120 kd
Dog CRP!;!
Rab bit CRPW 120 Jed
Cat CRpi
Rat CR~ Yes 125 kd
Mouse CRpl, , 101 200 kd
Chicken CRp!. 21 kd /subunit
Rainbow
t rout CR~ 5? 110 k d
Do qfi s h CRp!l 10 250 kd
Plaic e CRpi 10 Yes 188 kd
~~sucker 10 No? I SO k d
1JJn!.llJ.ui CRFLt 12 Yes 500 k d
lGotschlich and Ede l man (1965) ; ~iley and Coleman (1970)
!<Maudsley et a1., ( 1 9 87b ) ; !!Mauds l e y e t aI. , ( 19 8 7 a )
tRobey e t a I. , ( 19 84); !Bach e t a1. . ( 1977)
i p ep y s a n d Maudsley ( 1987) : !!de. Be e r a t a1.. (198 2a)
! Na gp u r k a r a nd Mo okerj ea (1981); lo liveira at a I. , ( L980)
kBodmer and siboo ( L977); l pe p y s et a l ., (1978a)
~inkelhake a n d Chang (19 8 2 )1 !!Robey a t a I., (1983)
.QPepys e t al. , (19828 ) ; IlFletcher et 8 1.. ( 1981)
lIRobey a nd Liu (198 1 ) 1 rF e r nandez- Mor a n e t 81. , ( 1968 )
Williams, 1978 ; Volan aki s at a L, 1978; Nagpurkar and
Mookerjaa , 1981) . Isolation of CRP from large quantities of
s e rum, pleural, or peritoneal fluids can be accomplished by
adsorbing CRP to the affinity resin in the presenc e o f
calcium and e luting with phosphorylcholine or a ca l c i um-
che lat i ng agent .
2) . G,n.ra1 Physicoohemical Properties of eRP
Molecular s h a p e
Typ i c a lly , CRP c omprises 5 i d entica l sUbunits (Ol ive i r a
et a1. , 1979 ). When exam ined under an electron microscop e ,
CRP appears as cyclic pentamers and has therefore been
referred to as pe ntraxins (Osmand et al . , 197 7) . Hu man,
rabbit a nd rat CRP all have this typical conformation. In
dogfish (Robe y et a1. , 1983), p laice (Pepys et a1., 1982a),
and lump su cker (Fl e tche r et a1., 1981) , CRP is compo sed o f
10 subunits . The se subunits eit her f orm t ....o pentameric d i s cs
i nt e r a c t i ng f ace-to-face or consist of 5 dim e rs which
aggregate i n a pentameric shape . One e xc eption t o the common
molecular shape of CRP is horseshoe cr ab CRP, ....hich assumes
a he xagonal ring-shaped structure c onsi s t i ng o f 12 s ubu n i ts
(Robey and Liu, 1981) .
The subunits in CRP are usually held together non -
c ova l e nt l y . Howev e r , i n rat CRP, three o f i t s five identic a l
subunits are non-covalently held together , while the other
two are covalently bonded through a disulphide bridge
(Nagpurkar and Hookerjea, 1981; de Beer et al., 1982a).
Compqsit'qn
CRP subunits consist of 205-218 amino acids (Gotschlich
and Edelman, 1965; Wang et a1., 1982 ; Nguyen and suzuki,
19864) . The moleCUlar weights of CRP r ange from 110 to 500
kd (Volanakis et aI. , 1978). In some species, such as rat
(de Beer et al. , 1982a ; Nagpurkar and Mookerjea, 1981), goat
(Haudsley et aI., 1987a), plaice (Pepys et aI., 1982a),
hamster rcee , 1977) and horseshoe crab (Robey and Liu ,
1981) , CRP subunits contain carbohydrate chains. In the case
ot rat CRP, which contains In (wi ....) carbohydrate (Nagpurkar
and Mookerjea , 1981), it has been shown that each of its
sUbunits is glycosylatl,d at position Asn-128 with a complex
biantennary oligosaCCharide chain (sambasivam et a L, , 1990).
In human (Gotschlich and Edelman, 1965) , rabbit (Robey et
aI., 1984) , cow (Maudsley at aI., 1987b), and lumpsucker
(Fletcher et aI., 1981), CRP does not contain any
carbohydrate . Therefore, based on their glycosylation
status, CRP can be divided into two classes: glycosylated
CRP and non-glycosylated CRP (Table . 1).
The stability of purified CRP is dependent on
temperature, pH, and protein concentration (Macintyre ,
1988). solutions of CRP at concentrations of 50 JL9'/ml to
1 mg/ml at p H 7- 8 are s t able f or weeks at 4°C and for months
a t _2 0 tl C. Unde r co nditions of lowe r pH or higher protein
concentration, CRP molecules t end t o aggregate . I n a lkaline
solut ions or with r epeate d f reeze-thawing, di s s o c iatio n of
CRP i nto su bunits or i ntermediate forms may be a ppre ciable .
3 ) . B inding Propert:lll ot e RP
Binding of eRP to phosphorylcholine
The ligand that CRP binds bes t is phosphorylcholine
(Vol an akis and Kap lan , 1 9 71) . substitution of t he phosphate
monoester g roup of phosp hory l choline with othe r acidic
g r oup s markedly decreases or abolishes the binding of CRP
(Young and Williams , 1978 ; Gotschlich, 19 82 ) . It has been
show n t hat the interaction of CRP wi th CPS and many other
c omple x polysaccha rides o f microbial , fungal, o r metazoan
pa rasite origin is mediated t h rough t he p hosphorylch oline
moiety of these po lysaccharides (Toma s z , 196 7; Pe r y and
Luf f a u , 1979). The higher affinity for phosphorylcholine
compa red with other phosphate monoesters suggest s that CRP
r ecognizes both the positively charged tr i met hy l a mmoni um
g ro up an d t he negatively charged phosphate group .
Human and r a bb i t CRP b i nd 5 mol ecu les of phos ph o ryl-
choline pe r molecule of prote in (Li u et a I. , 19 8 2) . Dogfi s h
CRP binds two phosphory lcholine molecules per subunit dime r
(Robey et a l . , 1983) . This suggests one p hosphorylchol lne
b i nd i ng domain on each s ubun i t o f CRP. one exception is rat
CRP, which binds thr ee , rather than tive, molec u l es o f
phosphorylchollne (Nag p u rk a r a nd Mook erj ea , 19 8 1 ) .
The b i ndi nq of phospho rylcholine by CRP requires that
CRP f irst binds c a lcium, us u a lly in a r atio of o ne to two
Ca z.. per CRP sub unit (Go tsch l ich a nd Edelm a n, 1965) . The
c on f ormat i onal c ha nq'e i nduced by Ca20 makes the p hosph o ry l-
choline bind i ng domain of CR P avai lable to the p hosphoryl-
cho l i ne l igand (Potempa et al., 19 81 : 'ioung an d Wil l iams,
1978 ) •
The amin o acid sequenc e of CRP has be en compared wit h
t he known sequences o f phosp horylchollne binding myel oma
proteins . On the basis of this c omparison , it has been
proposed that the s equ e nc e Phe-Tyr-M et-Glu in CRP may be
part ot its phos pho ry l c holine bi nding domain (Yo ung a nd
Will iams, 1978) .
Bind i ng of C;RP to po l y catioDS
In the absence o f c a l c iull ions, CRP b i nds pol yc a t i ons
su c h as po ly-L-lys l ne a nd poly-L-arglnine po l yme rs , l yslne -
rich and arginine- rich h i stone s , mye lin ba s i c prote i n, and
leucocyte cationic protein (S I egel et a1. , 1974; Potempa et
aI., 1981) . 1.t a pp ro pria te concentrat i ons of CRP and ligand ,
the complexes agg r egat e and p r eci p i t a t e .
In t he absence o f phosphorylchollne. calcium inhibits
t he interaction of CRP and p o l ycat i ons . However, i n t h e
presence of phosphorylcholine, calcium pr omotes rather tha n
i nhibits tineee i nteractions (OlC amelli et a1. . 19 80) .
4.). llcute Phase L,velll of eRP
CRP i n human (Zelle r , 1986), monkey (Riley and coleman,
1970), rabbit (Winkelhake and Chang ~9 8 2 ) , chicken (Pepys at
a1., 1978a ) , and r a i nbow trou t (Wink e lhaka and Chang 1982)
are typica l acute phase p r ote i ns . Normal sera in these
species contain on ly tra c e amounts of CRP. However, du ring
i nf lammation or tis!\ue damage. CRP concent:.r:ations in serum
dramatic a l ly i nc r e a se, sometimes up to several thousand-fold
over normal va lues . II) these s pecies , CRP is among t he fi rst
group of proteins t hat are synthesized at a great ly enhanced
r a t e during acute phase response, a nd t ermination o f the
stimul at i on is accompanied by the r e t ur n of their serum
co ncentrations t o norma l levels .
CRP in rat (Collins at a I., 19 84 ; de Bee r e t aI.,
1982a ) is a moderate ac u te phase protein . I t is p r es en t i n
substantial amount in norma l rat serum (0 .5- 0 .6 mg/ml).
During ac ute phase r eac t i ons, i ts serum concentration
increases by abou t two-fold (Collins et aI., 198 4 ) .
CRP i n cow (Maudsley e t a l. , 1987b), goa t (Haudsleyet
a1., 1987a), dogfi s h (Robey e t al. , 19B3 ) , plaice (Whi te at
al ., 1982 ) , and ho rseshoe crab (RObey an d Li u , 1981) a re
nomal components in t h e sera. They do no t undergo major
change in serum concent ration fo l lowing a n acute stimulus .
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D. BIOSnrrpSn NIP TURNOVER 0. e Rr
1 ) . Bionnth••h of CRP
Experiments co nducted in rabbits (Kushner an d Feldman,
19 78a ) o r with rat hepatocytes (Coll i n s e t aI. , 19 8 4) have
s hown t hat CRP is synthesized and secreted by the live r . ~
~ CRP synthesis has been demonstruted usi ng perfused
livers (Kushner et a l. , 19 80) . CRP ha s bee n i dent i f i ed
h istochemically in the cy toplasm of h e pat oc ytes bu t not. i n
a ny other type of hepatic ce l l s of r abb i t s during
inflammation (Kushner and Fe l dman , 197 8a ) .
2). I ncrea s e d CRP s ynthesis During acute Pha!lll~
I n s pecies in which CRP is an acute phase protein , the
peak l e v e l of CRP in serum correlates well with the se verity
of t issue damage (Kushner et a l ., 197 8b : Ar o nsen et al . ,
19 72) . Following a n acute stimulUs, i ncr ea s ed CRP synthesis
starts in the pe riportal a rea , and t h e n spreads to involve
a l l cells across the liver lobule (Ku s hne r and Fe ldmann,
1978a ) . The p eak lev e l depe nds on the durat ion of increased
CRP p roduction rather t han on the i nitial r ate of incre a s e
in synt hesis (Kushner e t aI. , 1978b) . These f ind i ngs
i ndicate that CRP is produced b y progressively i nc r eas i ng
nu mber s of h e p at oc yt e s after i nflammatory s timul us . They
als o sugges t t hat a cirC Ulating mediator(s), which 1s
r elea s e d in association ....ith inflammat i on and necrosis , is
responsible f or t he induction o f CRP synthesis . Th e r e is
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evidence that the circulating med i a t or s may be interleukin-1
(IL-I ) and interleukin~li (lL-6) (Moshage et aI. , 1988) . Both
IL-1 and lL-6 ha ve been show n to s timulate the synthes is of
CRP by the live r , but IL-6 is believed to playa key role i n
the process (Mo s haqe e t aI., 1988) .
3 ) . Other Bites of eR E Biosyn tbedl
Although liver is the main s our ce of serum CRP, it has
been shown t hat a s ubs et of peripheral blood l ymphoc y t e s are
al s o able to s y nthes i ze CRP f which apparently remains bou nd
to t he s u r f ac e of these cells . (Ikuta et aI. , 1986 ; Kuta and
8aum , 198 -:) . The biological significance of these findings
is no t c lear at present.
4) . 'In v i vo Cleara pce of eRP
The half- life of human CRP in the circu lat ion of no rma l
rabbits is about 4-6 h, and it remains the same during the
course of acute phase response (Chelladurai et a1., 1983) .
I n v i vo tur nov e r studies of CRP ha ve a lso been carried out
in mice and rats (Baltz et a1. , 198 5). The half-life of
human eRP in mice and that of rat eRP in rats were a l s o in
the r ang e of 4-6 h. The half-lives of t hes e CRP were
independent of their circulating l ev e l s an d were not
affected by CPS (Baltz at a l ., 1985) .
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E . P ROTEINS RELATED '1'0 CHP
1) . " rum. Amyloid P Component (saP)
Serum amyloid P compon e nt (SAP) was fi rst i dentified as
a compo nent of amyloid deposits i n humans (Cathc art at a1. ,
1965) . SAP and CRP in humans a r e similar to each other in
t he fol lowing aspects: i ) . They both be long t o a unique
family of protei ns called pentraxins. Their subunits are
arranged in an a nnular disc- like configuration with cyclic
pentameric symmetry (Osmand et aI. , 1977) ; il). There is
about 60," amino acid sequence homology be'tveen human CRP and
SAP (Osmand et a1. , 1977; Anderson and Mole, 1982) 1 iii) .
They bo t h have Ca2'-dependent binding ca pa city t o cer tain
liga nds (Pepys a nd Bal t z, 19 83 ; Skinner and Cohen, 19 88) .
novevee , whereas CRP has a strong Ca2'-dependent binding
property to phosphorylcholine, SAP binds to agarose, but not
to phosphorylcholine (Pepys et aI. , 1977a 1 Pepys et a1.,
1977 b) •
In ot her species, serum proteins wh Lch share ",ith human
SAP the property o f bindi ng t o agarose but not to
phosphorylchol ine h av e also been des ignated as SAP {pepya e t
a1. , 197 8a ) . SAP ha s been found in a lmost all vertebrate
species, including rabbit , rat , mouse, pig, goat , sheep,
donke y, human, CO"" marine t oad, plaice, f lounder , a nd
dogfish (Pepys at a1. , 19788 ) .
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2) . syr iap Hp,t er , . m. h pro~
I n syrian hamsters, a CRP a nalogue is ex pressed in high
levels only i n females (cee , 1982). Due t o its sex-related
distribution, t h i s protein is designated as hamste r female
protein ( FP) . I n nOr1llal adu l t fema l e syrian hams ter, FP is
present at high serum l ev e l s i n the rang'e of 0 .7- 3.0 mg/ml ,
while in norma l males the level is much l e s s (0 .01-0.02
mg/ml) •
Like CRP an d SAP, FP is composed of five i de ntical
sub un i ts a nd exhibits the pentameric structure {cce , 1983).
FP is a un i qu e protein in that i t can bind both Phosphoryl-
cho line and agarose in the pr e s e nc e o f calcium (Coe, 19 8 3 ).
The amino ac id sequence of FP has 691 hOMO logy t o human SAP
and so t homology t o human CRP (Dowton et a1. , 19 80 ) .
Althoug h FP b inds t o phos phoryl chol i ne , it has been shown t o
be a component of hamster amyloid deposits (cce , 1983 ) .
The refore , FP ap pears to be a homologue of both human CRP
a nd SAP .
3) . other Phosp '!:!Oryl oh oHn. Binding Pr ot e ins
Anti-phosp hory lcholi ne myeloma proteins
Anti-phosphorylchollne myeloma prote ins hav e
phosphorylchollne binding property . Howeve r, unlike the
phospho ry lchollne b i nd i ng of CRP, their binding of
phos phorylchol1ne is independent of ca" (Pollet an d
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Edlhoch , 1973 ) . Compared t o CRP, these proteins s how mu ch
l ess binding specificity tor the phosphate moi e ty of the
liga n d (You n g and Will iams , 1978).
Pe r f orin is a pore-forming pro t ein in cy t o lytic T-
l ymphocytes. I t ha s be en demonstrat e d that phosphorylchol1ne
ac ts as a Ca z·-d epe nde nt receptor molecule f or perfor in
(Ts cho pp et a 1. , 1989).
F . BIOLOGICAL ACTIVITIES or CRr
A number of biologi c a l properties of CRP have be en
reported , ba s ed on their interactions wi t h mac r omolecul es
and wi t h various types o f ce l ls . Most of the se prope rties
a re dependent on the phosphorylch oline bind ing property of
CRP.
1) . :Interactions ot eRr with complement system
The c las s i c a l comp l ement pathwa y ca n be act ivated by
CRP- CPS c omp lexes , agg r e ga ted human CRP or by c ompl ex e s of
CRP with phosphorylcholine-conta i ninq or c ation-conta ining
l igands (Kap lan and Vol an a ki s , 1974 : Cl aus et al ., 1977a;
Claus et a I. , 197 7bl Ri chards e t a1. , 1979 ) . Th e fu nctional
an d b i ological effects o f complement activation generated by
these complexes include opsonizat ion and l ysis (Horten s en
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an d Gewur z, 197 6a ; Mold e t a1. , 198 2 ) . Ph osp horylcholine has
been shown t o i nhibit this complement a c tivating activity of
CRP (Kaplan and Volanakis , 1974). The r efore , t he phosphor yl-
choline binding domain of CRP has been suggested t o be
involved i n the complement activating process .
It has been d",monstrated tha t human CRP select ively
de pos i ts on damaged tissue and necrotic cells, and binds to
membranes which hav e been s t ru ct urally altered (Volanakis
an d wirtz , 1979 ; Narkates and Volanakis , 1982 ; Vol a na ki s and
Narkates, 1981) . The binding of rat CRP to multilamellar
phosphatidylcholine llposomes has been shown to require the
disruption of t h e l i pos ome s tructure by the incorporation of
l ys ophos ph at i dylchol i ne (Nagpurkar et 21.1., 1983). The
binding i s specific t oward s the po l a r phosphorylcholine he a d
groups on the s urface of t h e liposomes . Similar results ....e re
obt a i ned from t h e binding studies of human CRP to
unilamellar liposomes (Volanakis and Wirtz, 1979) . More
importantly, SUbsequent to the b i nd i ng of CRP to damag ed o r
a l tered cell membra nes , the complement path....ay was s hown t o
be ac tivated (Volanakis and Wirtz , 1979). I t has t herefore
b'''2n sug ge sted that CRP r e c ogni ze s dama g ed cells~,
and by SUbsequently activating t h e complement path....ay ,
generates t he chemo tactic and opsonic activities requi red to
promote phagoc y tosis , leading eventually to the resolution
and r epa i r of t h e l e s i on (Volanakis , 1982) .
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2). InteractioD' ot eRr YUh Lymphoid By't."
A possible interaction between CRP and lymphoid cells
was first suggested in 1937 by Abernethy and Francis when
they reported a delayed skin reaction to CPS in patients
with elevated serum levels of CRP (Abernethy and Francis,
1937) . This suggestion was s uppor t e d by the observation of
Wood et al (1 953) . They found that, while immunizing
rabbits, animals which produced CRP in response to the
injection of antigen had higher titer of specific antibody
against the antigen than those which failed to produce CRP.
In addition, Williams et at. ( 198 0, 1982) reported the
presence of CRP on the surface of 1.0-35\ of peripheral
lymphocytes of patients with rheumatic fever,
poststreptococcal cholera, or acute streptococcal
infections.
A number of~ experiments have provided more
direct evidence of the interaction of CRP with T-
lymphocytes . Fluorescein-labeled CRP was shown to bind to
peripharal blood lyrophocytes (Oishi et at., 1973 ). The
binding of CRP to lymphocytes could be inhibited by
phosphorylcholine or by pre-treatment of the cells with
phosphl)llpase C (Hornung , 1972). Mortensen et at. (1975)
observed that purified human CRP inhibited rosette
formation, proliferative responses to soluble antigens and
to allagenetic cells in mixed lymphocyte culture . Further
experiments demonstrated a selective binding of human CRP to
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antigen-stimulated lymphocytes (Croft et a1., 1976) . The
amounts of migration inhibitory fa ctor and macrophage
chemotactic factor synthesized by antig e n-st i mul a ted and
mitogen-stimulated l ymphocytes decreased when the
lymph ocytes were cu l t ured i n the presence of CRP (Mor tense n
et a!., 19 77).
3) . Ertect ot CRP on the Actiyity of Phagocytic C.lls
In 1951, WOOd. reported that moc1e s t co ncentrations of
purified human CRP or acute phase s e r a with low levels of
CRP markedly s t i mulat ed the mi g r ation o f human polymorpho-
nuclear l eu c ocytes , whereas high concentrations of huma n CRP
i nhibited this mi gration (Wood, 1951) . Hokama et a1. showed
that the rate and degree of neutrophil phagocytosis of
s t r a i ns of s t r e ptococci pneumoni ae and serrat i a Marcescens
and of carbonyl iron spherules in whole blood were increased
by the addition of hu man CRP ( in t he r ange of between 10 and
30 JLg/ml ) (Hakama et aI., 19 62) . Subse quent l y, Ganrot and
Kindmark ( 1969 ) and Kindmark (1971 ) demon strated the
phaqocytos is-promoting effect of CRP in s e r um- f ree~
aGsay s ystems using a wi de r a nge of bacterial s peci es , and
s ucceeded in reco vering CRP from bacterial s u r f a c es
(Kindmark, 19 72). In add i t i on, Mortensen et a1. (197 6)
observed that the number of monoc ytes ingesting CPS- c oat ed
erythrocytes was reduced from 82' to 13' when CRP was
re moved f r om the erythroc ytes that had reacted with CRP and
,.
comp lement . Re-addi t ion of CRP restored t he i ngestion t o
76%, indicating a requi rement of CRP in tri g ge ring
p h agocy t os is •
Recently, r a t CRP has been shown to occur as a
membrane-associated protein co ns titutively expressed on
liver mac rophages (Kupffer ce lls) (Kempka et 211., 1990 ) . It
functions as a ga lactose-specific receptor for the binding
of part iculate ligands . This membrane bound rat CRP has been
shown t o be identical to serum rat CRP and could be
functionally replaced by purified ra t CRP.
4). EffeClt_ o f CRP on Platelet Punctions
cevu e e and Fiedel were the fi r s t t o demonstrate that
h uman CRP inhibits platelet aggre gation s timulat ed by ADP,
epinephrine , o r t hr ombin ( Fiede l and Gewurz, 1976a 1 Fiedel
and Gewurz, 19 7 6b). The i r r es ult..s suggested t hat t h e
inhibitory effect of human CRP o n platelet activities mi ght
be due to an i nterference with prostaglandin metabolism
(Fiedel et 211., 1977) . I t was afterwards shown that a low
molecu lar weight factor in CRP p reparations was essentia l i n
t h i s inhibitory effect of human eRP (Fiedel et 211., 198221) .
Subsequent ly, rat CRP was s hown to inhibit platelet
a ggreg a t i on induced b y plate let -activating facto r (PAF) in a
dose-dependent manner (Nagpurkar et 211 . , 1988 ) . Ra t
p late l e ts are norm al ly r e fractory to aggregation b y PAF.
Howeve r , when r a bb i t antiserum a gains t rat CRP was added to
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rat platelet-rich p l asma , aggregation of rat p l atelets by
PAr was observed . In addition, rat CRP also inhibited PAF-
i nduc ed aggregation of human platelets in a dose-dependent
manner . I t was suggested that the high con c ent r a t i on of rat
CRP present i n normal rat serum could be the cause of t he
refractory r e spons e of rat platelets to PAF. Li ke rat CRP,
rabbit and human CRP hav e also been shown to i nh ib i t
platelet aggregation i nduced by PAF (Vigo , 1985 : Kilpatrick
and Virella, 1985) .
Using an HPLC-g el f ilt r a tion technique, rat CRP has
bee n shown to b i nd to PAr (Randell et al ., 1990a) . The
format ion o f the rat CRP- PAF complex was calcium dependent
and could be inhibited by phosphorylcholine , suggesting the
involvement o f the phosphorylcholine binding domain o f rat
CRP. The binding of CRP to PAF has been us e d to eKplain the
i nhibitory eff ect of CRP on PAF- i nduced aggregation of
platelets (Randell et al . I 1990a) .
Rat CRP has been shown to bind to platelets (Ra nd ell et
a1., 199 0b) . It has been suggested that the binding of CRP
to the surface phospholipids of platelets through its
phosphorylcholine binding doma in may contribute t o its
i nhibition of platelet activities (Fiedel et a1., 1976c :
Randell et a1 . , 1990b) .
5 ) . J ptar.crUoA ot CRP with Plasma Lipop roteins
Using immobil ized rat CRP on Sepharose 4B, it was show n
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t hat rat CRP selectively bound ape B and E containing
lipoproteins (Saxena e t aI., 1987a) . Huma n an d r abbit CRP
have been s hown t o have s i mi l ar reactivity with apo B
containing lipoprote ins (de Beer e t a I. , 198 2b ; Rowe et a1. ,
1984a) . This b inding of lipopro teins was ca lcium dependent
and the bound lipoprot e in s were eluted by phos ph or ylc holine .
Therefore, it presumably involves t he phosphorylcho line
binding domain of CRP.
In rabbits, s ome or a l l of the CRP in acute phase serum
ex i s t s as a co mplex with e ither low density lipopr ot eins
(LDL) or very low de nsity l i p oprot e i ns (VLDL) (Pontet et
a l ., 1979; Cabana et a1. , 1982 ) . The formation of these
complexes depends on t he concentration of apo B con taining
lipoproteins in the serum (Rowe et a1. I 19 84a ) . I n humans ,
CRP co -exists i n t he circul a tion wi t h pla s ma l i p i ds or
lipopro teins, but does not bind t o them o r form comp l exe s t o
any ap preciable ex tent (de Bee r et a1. I 19 82b ) . However, i n
the serum of patients with t ype II I hyperlipoproteinemia ,
which contains the a bnormal lipoprotein P-VLDL, the
formation of CRP- lipoprotein complexes was demonstrated
(Rowe et a1. I 19 84b ) .
Investigations on the e f fect of r at CRP on the binding
of human LOL to LDL r e ce pt ors on l i ver ce l l membranes f r om
est r a di o l - t reat e d r ats showed that r at CRP inhibited the
binding of LDL to these r e c ept ors (saxena et a1. I 19 86) . I t
was shown that this i nh ibitory effect of r at CRP could be
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due to the tomation er a LDL-rat CRP complex, rather than
the binding ot" rat <:RP to the LDL receptors (Saxena et al.,
1986) •
I1I\lllobilized rat CRP has been tested for its
effectiveness to bind plasma VLOL and LDL using a
extracorporeal plasmapheretic system with rabbits (Saxena et
aI., 1990). Results showed that sepharose-rat CRP columns
bound some circulating plasma lipoproteins and most ( >90%)
of the bound lipoprotein fraction contained VLDL and LDL.
The interaction between CRP- and apo a-containing
lipoproteins may have important .in..-.YJ.yg functional effects .
By binding to damaged cell membranes and then selectively
interacting with apo a-containing lipoproteins, CRP may
contribute to the specific localization of lipoprotein
particles required for active cellular metabolism or
processes of repair (Pepys et a1., 1985) . This may be
relevant to the pathogenesis of atherosclerosis .
6). eRr in Derenoe ",cbagh;, agaig8t Inflction and th,
Chlrano. of' l.bDormal "at,rials from ciroulation
The phosphorylcholine binding properly of CRP enables
it to recognize and bind a wide range of either
microorganisms or their degradation products . It has been
suggested that CRP may reduce the toxicity of the
microorganisms by simply binding to them. Besides, secondary
processes such as complement activation and phagocytosis may
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a lso contribute to protection against infection (Yother et
a l. , 1982) . This role ot CRP has been demons t r ated by an
experiment in which human CRP was shown to p rotect mice from
l e t ha l streptococcus pneumoniae i n f e ction (Mold et ar . ,
1981a). This result supports the concept t h a t CRP may act i n
t his way both in c er t ain primitive a n i ma l s , which ha ve no t
evol ved s pe c i f i c an t i bod y mechanisms , and in more de ve loped
animals a t a n early s t a ge of infec tion, before the
production of sp ecific antibodies get under way .
s tudies on t he interaction between CRP and certain
abn ormal materials n av e also provided ev idence that s upp ort
the rol e of CRP in defense mechanisms (Pepy s , 1981). Human
CRP has be en shown to bind to ch romatin in t he p resence o f
ca lcium (Robey et a1 ., 1984 ) . I t has also been s hown t hat
human CRP mediates the solubiliza tion of c h r omat i n by
complement (Robey et a 1. , 1985). In addition , CRP from rat
and ho rseshoe crab have been fo und t o b i nd mercury both in
~ a nd~, and i t ha s been suggested that CRP may
act as a scavenge r for t ox i c metals (Agr awa l and
Bhattacharya, 1989) .
7 ). Clin i cal l\ppHcaUons of CRP
During severe infections , CRP con centration i n serum
i ncre a s e s , a nd the actua l d eg r e e of increase us ua lly
corresponds with the s ev e r i t y of t h e i nf e c t i on (Sa be l and
Hanson , 1974 ; Mood l ey , 1981 ) . Based on these obs e rvatio ns ,
2 3
measu r emen t ot serum CRP has be e n us ed i n clinical
diagnosis, especially i n d i s t i ngu i s h i ng bac terial intections
trom viral o nes , and in the ma na g eme nt ot a wide r ange of
c lini c a l condit ions (Table 2) .
Table 2. c U .Di cal 1pplicatioll.s o f t be Me.s uremell.t ot Serwa CRP
screening tor o rganic d i s e a s e
Moni toring the extent and ac tivity ot disease
Inf ect i on
Inflammat i on
Ma ligna ncy
Necrosis
Detection of infect ions
(Taken f rom Pepys and. Baltz (1983 » .
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section rz , GLYCOPROTUN t NfO~
Glycopr ot eins are prot eins t o which ol igosaccharides
are co va lent ly attached. I t i s we ll known t ha t the
ca rbohydrate c ha ins on g lycopro teins p lay important roles i n
their b i ological f unctions and met abol i sm. The c l e a r anc e o f
g lycosylated CRP has been examined in this s tudy . A brief
outline on t he structura l fea tures a nd ca rb ohy drate-
depe nde nt c learance mechanism of glycoproteins i s the refore
provided in t h i s sect ion .
A. STRUCTURE or GLYCOPROTEINS
1 ). composition of the Carbohydrate Moiety of alycopr01;eins
Although at lea s t 200 dif:fere nt mon os acchari des have
been discovered in n a t ure , only 11 are known to occur i n
glycoproteins (Sha ron an d Li s , 1981 ) . Most o f t he s e
monosaccha rides a r e hexosee or t he i r simple deriva t i ve s ,
such as N-acetylhexosami nes an d ur onic acids . In ad dition,
many a n ima l g lycoprote i ns con ta i n more compl ex mono -
s acchar ides , e .g. , t h e s ialic acids . I n g lycoproteins , the se
monos a c chari de s exist as residu es in oligosa ccha r i de chains.
The red ucing groups a t t h e end of t he s e ollgosac c harides are
i nvo lve d in t he ca rbohyd rate-pept ide l inkag e .
2) . C'.lrbohy4rab-Polypepti4ll....Li..nmn
Th e ca r bohydrate cha i ns on glyc oproteins a re c lass i f ied
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according to their linkage to the polypeptide chains
(Kornfeld and Kornfeld , 1980) . A carbohydrate chain is
termed an N-linked or asparagine-linked oligosaccharide if
it i s attached to the amide group of an asparagine side
chain (Fig . 1). On the other hand, if a carbohydrate chain
is attached to a hydroxyl group in the side chain of serine,
threonine, hydroxylysine or hydroxyproline , it is called an
a-linked oligosaccharide (Fig . 1).
In most glycoproteins that have been examined so far,
the carbohydrate chains seem to be preferentially attached
to peptide sequences forming ,a-turns (Rademacher at al.,
1988) . Where N-linked oliqosaccharldes are attached, the
amino acid sequence next to the glycosylated asparagine is
always asparaginyl-X-serine/threonine (X can be any amino
acid except glycine). In glycoprotelns where more than one
N-llnked oligosaccharide is present, several amino acids
separate the sites of attachment of the carbohydrate chains.
In contrast, a-linked oligosaccharldes may be attached to
neighbouring amino acid residues .
3) . oligonccbaric!es in Glycopr0t.ein,
N-linked oligosaccharides
The N-linked oligosaccharides are by far the most
conncn ones found in glycoproteins (Kornfeld and Kornfeld,
1985) . A conaon feature of N-linked oligosaccharldes is that
they have a common inner core, consisting of a branched
26
Fig . 1 . tla j or Types of Carbohydrate-peptide
Linkage
1. N-glycosidic linkage
GlcNAc --- Asparagine
2. a-g lycosidic linkage
CK.OK 0 r ):_ o~°'v-- 0 -ox-o
H~:c.. <:..
• P.p~:l.d .
c h a :Ln
GalNAc --- Th r l S e r
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pentasaccharide: trillIannosyl-d i - N- ac e t ylg I uc osamine
[HanJ (GlCNAC)2 ) (Fig . 2).
nc. a. Th. cemmeD. OOrll of N- lluk ed eU,CHlaooharlda
1I.. . Cl••>
....~ (I - ') GleNAo~ (,.. ' ) G1eNA'
Uana(1"'3)
a4apu4 from 8Jluoa. IUMI UI (1111)
The pe riphera l mannos e residues are usually
substituted. Due to these substitutions, t h r ee majo r types
of N-linked oligosaccha rides are formed : t he high-maDnose
type (oligomannosid1c type), the complex t ype, and the
hybrid type of oligosaccharides (Kornfeld and Kornfeld ,
1985). Typica l examples of the three t ypes of N-linked
oligosaccharides a re shown in Fig. :1.
The high-mannose oligosaccharides typically have two to
s Ix additional mannese r e s i due s linked to t ne penta -
saccharide c o re, Whereas the c ompl e x oligosaccharides
contain a d i vers e gro up of additional sugars to the core
structure . The hybrid oligosaccharides ar e so named because
they have f eat ures of bo th high-mannoss an d complex
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ol lgosaccharldes .
The common pe ntasaccharide o f N-linked oligosaccharides
may be modified both by the addition o f extra sugar r es i d ue s
that elongate the outer cha ins a n d by the addition of ex tra
br anche s to the a mannos e res idues of the co re s tructure .
The outer b ranches of the ollqosaccharides are also often
referred t o ali a ntennae of t he o l1qosaccharides. The
ma j o rit y of N-l inked ol iqosa cch a rides c on tain t wo, t hree, or
f ou r an t ennae (Paz-Parente e t a l. , 1982 ; Yamashita e t al. ,
1983 : Franco i s-Ge r a r d et a L , 19 83) .
The high-mannos 8 ol iqosacchar ide s oc c ur i n ani mals ,
higher plan t s , yeas t , and f ungus glyco prote i ns. On the o t he r
hand, complex oligosaccharid e s appear to be co nfined to
an ima ls. I n mammals , no mor e than six mannose resi du e s
at tached t o the core s tructure h ave been found . But more
prl1ltltive organisms, s uch as yeast. may contain much lal:ger
high -Illannose oligosaccharides (Schachter, 1984) .
O- linked 0 1 iqQS1lcsbu'des
I n contrast to N-llnked ol igosaccharides. tev
generaliza tions c an be made abo u t a - linked oligosaccharides .
The ca r boh yd rate structures vary f rOID a single ga lac tose
residue (e . g., i n colla gen) to branche d Ol!qos acchari de s o f
up t o 16 t o 18 monosac c har i d e res iduBs (e. g . in so luble
bl ood group sUbs tances). Perhaps the only common feature i n
the structure of a -linke d oliqosa cch a r i d e s i s t he GalNAc
'0
a ttached t o t h e hy dr oxyl group of s e rine or threoni ne i n
many O-linked o ligosaccharides (Fi g . 3) .
B. BIQBXNTHEBIB QP GLYCOPRQTEINS
The polypeptide chains of glycoproteins are s ynt he s ized
i n the s ame way as non- g l yc os y l a t e d proteins . They are
assembled on membrane -bound r ibosomes on rough endoplasmic
r e t i cu l um, under direct con trol of the ge netic code . The
initial g lycosylation occurs either while the polypeptide is
still na s c e nt; on the ribosome or shortly after trans lation
h a s been completed .
Unlike t he polypeptide chains , c arbohyd rate c ha i ns in
glycopr ot e i ns are not prima ry gene products . They are
synthesized by e nzymes known as glycosyl t r an s f era s e s
(Rademacher e t a1. , 1988) . These transferases a re bou nd t o
t h e metnbranes of the endoplasmic r etic ulum or the Golgi
apparatus . They act in a very specific order, without using
a template, but. rather by r ec ogn i z i ng t he actual structure
of the growi ng oligosaccharide as t he appropriate substrate .
This type of synthesis is not ve ry accurate and t he r ef o r e
r e s ul t s in mlcroheterogenei ty in the carbohydrate moie ty of
g lycop rot eins . j.' or ex ample , o:l-acid g lycoprotein (AGP) from
human -erun ha s a t l e as t 19 variant carbohydrate structures
at the five a t tachmen t s ite s a long the po lypeptide chain .
For O- linked ollgosaccharides, t he suga rs are added one
at a time t o the polypepti d e c halns . Usua lly GalNAc is added
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first, which is elongated by a variable nUmber of additional
sugar residues, ranging from just a few to 10 or more
(Ruoslahti, 1988).
Unlike the synthesis of a-linked oligosaccharides, the
initial step in the synthesis of N-linked o1igosaccharides
cannot be accomplished by the addition of i ndividual sugars
to the polypeptide chains . Rather, it requires the transfer
~ of a single species of oligosaccharide, containing 3
Glc , 9 Han and 2 GlcNAc residues, from dolichol pyro-
phosphate oligosaccharide to an asparagine residue in the
polypeptide chains (Kornfeld and Kornfeld, 1985). The
oligosaccharides are almost always transferred to growing
polypeptide chains, ensuring maximum access to the target
asparagine residues.
Once initial glycosylation has occurred within the
rough endoplasmic reticUlum, the oligosaccharide is trillU'Ded
immediately. The trimming process continues as the glyco-
protein is transported to Golqi apparatus . The diversity of
the oligosaccharide structures on mature glycoproteins
results mainly from this extensive modification of the
original oligosaccharide (Berger et a1., 1982 ; Kornfeld,
1982; Schachter et a1., 1983) .
C. CLEARANCE OF QLYCOPRQTEINS
Proteins are degraded in a controlled manner during
normal growth and differentiation (Rechsteiner et a1. 1987).
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In addition to features such as conformation o f the
pOl ype pt i d e , the carbohydrate moiety has been shown to play
an important role in r egul a t i ng the catabolism ot
glycoproteins . Several carbohydrate-dependent c learance
pathways for g lycoproteins hav e been discovered.
1 ) . Clearance of g lVcopr otei ns tbrp ug b t b . HepaU"
Asia1oqlycoprotein Rlpe ptpr
In the l l:lt e 60 I s , Ashwell and Morel l discovered that
the c learance rate o f ceruloplasmin, a co pper t r ansp or t i ng
g lycoprotein in serum, was dramatically en ha nced when its
t e rmi na l sialic acids were removed by neuraminidase
treatment (Ashwell and Har f or d , 1982) . The asLeLo-
ceru loplasmin was rapidly t aken up a nd degraded in the
liver . Similar reSUlts were obtaine d wi t h othe r mammali an
serum glycopr ot e i n s . Detailed investigations o f this
phenomenon revealed a receptor f or asialog lycoprotelns on
the s urface of hepat ocy tes (the he patic asialog lycoprotein
receptor). This receptor r e cogni ze s t he termi na l galactose
r esidues o f a variety of as ia loglycoproteins a nd mediates
t he up take of as ialoglycoprote'i ns into Lysos en e e for
hydrolysis. ThUS , a c learance pathway for mammalian
cirCUlating qlycoproteins h as b een established , which is
often r e f erred to as Ashwe l l 's pathway (Fig . 4) .
The hepat ic asialoglycoprotein receptor has be en
isolated and purified (Schwartz and Ashwell , 1984) . nue t o
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i ts l ect i n-li ke specitic binding to galactose a nd the fil e t
that the bind i ng can be s pec ifica lly i nhib i t e d by Ga l NAc,
thi s r ec e ptor is a l s o called hepa t i c Gal/Ga l NAC s pec i fi c
l ect in . I t i s the ~irst a nimal lectin disc ov e red an d
characterized. Simila r t o plant l ect i na , t h is l e c t in a l s o
agg lutinates neu r amin i dase- t reated cells and is mi t og eni c
f or l Ylllphoc yt e s . Th e s e prop e rties impl y mul t i - v a l enc y of
bind ing sites on one f unctio nal l ectin molecu le .
The bind i ng an d u p t ake of a s i aloq l yc oproteins into
hep a tocytes al s o s e em to re ly on lIIul t i p I e i nter a ctio ns of
the asialoglycoprote ins with t he hep atic aaialoglycoprotoin
r eceptor (Baenziger a nd Fiete, 19 80) . As i a l og l y c op r o t e i ns or
puri f ied asialoqlyc opept i de s .... i t h mu l t i ple t e rm inal
ga lactose residue s ar e bound wi th high aff i n i t y t o th i s
r ec e pt nr an d a r e r apidly t aken up i nto the c e l L Asialo-
glycop roteins wi t h two or les s tem i na l ga l actose res i due s
us u a lly bind poorly . Thus as i alo AGP, whIch has . an y t ri- o r
tetraantennary N-linke d oligos ac cha r i de s , i s an ex cellent
subst r a t e for th i s r eceptor , wherea s serum as1a lo-
tran s ferrin with b i a nten nary oligosaccha rldes is a p oo r
s ubstrat e (Ha t ton e t a1.. 19 79).
Sialic a cids ha ve be en sh own to playa dual rol e i n
this c learanc e pathway (Hudgin et a1. . 1974) . On one ha nd,
the re moval o f t ermina l s i a l ic acids f r om g l y c c pr otei ns is a
pr e-requ ireme nt f or their binding to the hepatic asLako-
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glycoprot ein re ceptor . On the other h and , the pres ence of
sialic ac i d s on the re ceptor i s nec e s s ary t o keep t h e
r eceptor biolog i cally fun ctional . Ne u r amin i da s e t reataoent of
the hepatocytes or the purified hepat i c a s ialogly c oprote in
recep t or r e sulted in c omplete i nhi b i t i on of the i nteracti on
between as i a loglyc opro teins and t he hepatic r eceptor. The
r emoval of sialic a c id s from the ca r bohy d rate c h ains of t he
hep atio r ec eptor induc e s s el f - ag greg a tion t hr ou gh inter -
action with 8xpos e d ga lac t os e t erminal residues , and impa i r s
its b inding of as i a 1og1ycopr o teins .
2 ) . Other Carbobydrat_- dap_ndent cl••ranca Mechanhms
Clearance sys t ems in wh i c h su g a rs other than galactos e
s erve a s determinants have been id e ntified . Besides h ep ato-
c yees , non- pa r en ch ymal cells in t he liver, particularly
Kupffer cells , also pl a y an im por t a nt role i n the c l earance
o f g l y copr o t e i ns .
After AGP has been s uccessi vely treated wi t h
neurami nidase and ,a-galactosidase to expo s e its Gl eNAc
residues, t he modified p rote i n is rapidly t aken up by the
reticuloendothelial system in t he live r . Hann a s e-terminat ed
g l yc o p r ot e i ns are cleared i n a similar way (stahl et a L, ,
1976). The re fo r e , the l ecti n on t he surface of Kupffer cells
b inds glyeoproteins carrying e i t her terminal GlcNAc or Man
res idues .
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An ana logous lect i n is also wid ely d i s t r ibuted on
phagocytic cel l s , e .g . a lveol ar macrophages . Th e funct i on of
the above mentioned l ect i ns may i nc lude t he clearance of
aged or partially deg r a ded serum glycoproteins f r om t he
c i r c ul a t i on , an d the d e s t ructi on of microorgan isms , such as
yeasts , which a r e rich in o l igomannosidic chains . The
ingestion of yeasts by alveolar macrophages, fo r examp lo, is
inhibited by mannose a n d glycoproteins with termina l mannose
residues (Warr , 1980 ) .
Unlike mammalian serum g lycoproteins, normal c ircu-
lating g lycopro teins in avian species usually p o s se s s
ex posed ga lactose residues . Obvious ly, therefore , clearance
via the hepatic Gal /GaINAC s pecific l ec t in cann ot exist i n
these species . I t was found that i n t he s e species a
cl e a r ance system which r ecogn i ze s t e rmi na l GICNAc residues
of glycoproteins ope rates on the surface of t h e hepatocytes
(Re g oec z i et aI., 197 5) . The e legant wor k of Regoecz i and
his co -workers s howed that t tle half-li f e of avian g lyco -
prote ins was dramatica l ly d e c r ea s ed after being t r e ated wi t h
,a- g a l act os i das e to ex pose their penUltimat e GlcNAc r e s i du es
(Re goeczi e t a1. I 1975) .
It has been found that the car bohydrate binding domain
of several c l one d anima l l e c t in s s hare s ome COml1lon f e at ur e s
in the i r ami no acid sequences (Drickame r, 1988 ). Homo logous
carbohydrate binding d oma ins have a lso been found i n othe r
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ani mal l ec t i n s . By searchinq t he kno wn prote i n sequences tor
the carbo~ydrate ~indin9' motit , add i t i ona l animal le~tins
have been discovered , inc ludinq pUlmona ry surfactant p r o t e i n
A, proteoqlycan corG prote ins, and lymphocyte r e cept or tor
the Fc portion ot I qE (Dr i c kame r, 19 88) .
3.
Section III . PORP08I! or TR£ PRESENT nODY
As described earlie r in thi s chapter, CRP investigated
so far are a l l sy nthesized mai n ly in t he liv e r . Howeve r,
their catabolic path way is not c lear. Base d on Ashwe l l's
discovery , t h e he pa tic asialog lycoprotein r e c eptor is a
potential site fo r t he clearance of mamma l ian circulatory
g lycoproteins . Rat CRP, being a se rum glycoprote i n , offe red
us an oppor t un i t y to study i ts clearance by Ashwe l l 's
pathway .
Since no t al l CRP are glycosylated , i t is appropriate
to de termine if g lycosylated CRP an d non-glycosylated CRP
follow different c l e a r anc e pathways . CRP b inds to
ph osphorylch o l i ne , and t he ce l l su rface is a bunda nt wi th
phosphory1cho1 ine residues . I t is t he r e t or e r el eva nt t o
examine if the phosphory1chol lne bind i ng property of CRP
wou l d affect the binding of asialo CRP t o t h e hepatic
asia log;J.y coproteln receptor and the a ubaequ e nt; clearance of
t hese proteins through this r e c ep t or .
I n the pres ent study , the b i ndi ng of rat as ia l o CRP,
rat CRP and rabbit CRP to Isolated hepatocytes has bee n
exami ned . The c learance of these prote i ns h a s been
i nvestigated~ and a lso using perfus e d r at l i ve r.
competitive inhibition experime nts hav e be en carried out .1n
ill1:2 and~ between r at asialo CRP a n d asia lo AGP . The
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effect of GalNAc and phosphorylcho line on t he b i nd i ng of rat
asialo CRP has been s tudied , r a t a nd rabbit CRP to isolated
hepatocytes and on t he clearance of t he s e proteins by
pe rfused l i v er .
40
CHAPTER 2 MATESUL8 ANJ) MEtHOps
A. IllInl\1.M&
1 ). An i mal s Male Sprague-Oawley rat s (body weight 250 -300
g) and male whi te New Zea land rabbits (b od y weight 1 .5-2.5
k.g) ver'e purchased from Charles River Canada Inc., La
Praire , PQ and were fed chow ad libitum .
2) . Reaq8n~!!I a M c hem i cal. waymouth 'B HB 752 /1 medium ( IX)
was from Gibco laboratories, USA . Nal2S1 (reductant free ,
2mci in 4-5 ~l 0 . 1 M NaOH) solution was f rom Du Pont Canada
Inc . Cyanogen bromide (CNBr) activated Sepharose 4B was f rom
Pharmacia . lodo-Gen ( 1 ,3 ,4 , 6-tetrachlorO-30: , 60:-
diphenylglycouril) was f rom Pierce . Neuraminidase f rom .!a....
pe rfringens (EC 3 .2 .1 . 18), col lagenase from £l..:-
hfstgl y ti c u m, type IV (EC 3.4 .24 .3) , O: l-acid g lycoprotein
(BOvine) , Sephadex G-25- 150 (bead size 50 -150 JL) and all
other chemicals we re from Sigma Chemica l Company.
3). Me dium and Buffer~ Waymouth 's MB 752/1
medIum plus 0 .2\ (w/v) bovi ne serum albumin (BSA) (pH 7 .4) .
Hanks ' buffer ' 0 .137 M NaCI , 26 DIM NaHCO" 0 . 34 rnM Na2HPo"
0.44 mM KHzPO" 0 . 5 mM EGTA, 0 .8 mM MgSO,' 7H20, 5 . 4 llIM KCI
(pH 7 .4) . Kreb's -bicarhonate /B SA' 118 mH NaCI , 23 .8 mM
NaHeo" 0 .95 mM KHzPO" 1 . 2 mM MgSO,~7H20 , 4 .8 mM KCl, 2 .9 mM
4 1
CaCl z·2HZO, 0. 25l BSA (pH 7 .4) . Trig bufter · 5 mM Tris-HCI
butter (pH 7.5 ) containing 0. 1 5 M NaCl and 2 mM c a z-.
B. PRlpnauYl PROCEDURES
1) . p r e para t i o p o t seDba rose-pb eDylphospborylcholine
Affinity llds o r be nt The affinity ad s orbe nt fo r t h e i solation
a nd puri fication of rat a nd r abbit CRP wa s prepare d as
de scribed by Nagpu r ka r and Hook erjea (1 981) . Typically , 4-
n i t r oph en y l - phos ph oryl c h oline (0 . 6 9, 1.19 nmol) i n meth anol
(50 ml) was r ed uced with Hz at 1 atm u s ing 0. 2 9 of 5%
palladium on charcoal as catalyst for 2 h at room
temperature. The reaction mi xture ....as filtered a nd the
filtrate e vapor ated un de r reduced pres sure . The r e sUlt ing 4-
aminophenylphospho rylcholine ....as i mme diat e ly dis s olved in
1 00 ml o f 0 .1 N NaRCo) buffer (pH 8 .3) containing 0. 5 M NaCI
and ....as added to 15 g of CNBr - a c t ivated Sepharose 48 h i.ch
had been previously ....a shed with 1 roM HCI. The mi x t ure a s
gently mixed for 4 h at room temperature , filtered a nd then
washed alternati vely with 0 . 1 M NaHCD) buffer (pH 8.3 )
containing 0 .5 M NaCl and 0. 1 M CH)COONa buffer (pH 4.2)
co nt ai n i ng 0 .5 K NaCI. The Sepharose-phenylphosphol.ylcholine
was treated overnight a t 4°C with 200 ml of 1 M ethanolamine
(pH 9 .0) and finally re-sus pended in 5 \lIM Tris-Hel (pH 7.B )
a nd s t ored at 0- 4°C.
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2). Prlparation of R.t and Rabbit Ser. Rats were
anaesthetized lightly wi t h ether, the abdomen cut o pen an d
blood obtained from the abdominal ao rta. 'l:he blood was
a l lowed to c l ot for 1 hour at room temperature fo l lowed by
another hour at 4°C. I t was then centrifuged for 5 min at
1, 000 Kg in a bench t op centrifuge. The s er um was taken out
and use d i mmod i a t el y or s tor ed at _20°C until use .
Inf lammation was induced i n r abbits by subcutaneou s l y
i njecting turpentine (0 .5 ml /kg b ody weight) in the t highs .
Blood was obtained after 48 h by cardiac puncture from
rabbits under a r.aesthesia induced by i ntraperitonea l
injection of sodium phenobarbital (1 ml / kq body weight) .
Serum was prepared as described f or rats .
3) . Isolation and Purification ot Rat and Rabbit eRP Rat
CRP and r abbit CRP were i solated an d pu rified f rom normal
rat serum and inflamed r a bb it serum, r e s pective l y , according
to t he procedure of Nagpu rJcar a nd MooJcerjea ( 19B1) .
Se pharose- phenylphosphorylcholine affinity a dsorbent was
packed i n a co lum n (20 x 2 em) a nd equilibrated wi th 5- 10
be d vo l ume of Tris buffer at a f low r a t e of 1 ml /min . Se rum
«40 ml) was brough t to a concentration of 5 tnM wi t h respect
t o Tris-HCI , 2 111M wi th r e s pe ct to ca Zo, and applied on the
column. The co lumn was washed ex tens ively with Tris buffer
un t il absorbance at 280 nm of t h e eluen t wa s l es s than 0 . 02 .
CRP was then e luted with 8 roM phosphor y lcholine i n Tria
"
buf fe r. After dia lys i ng e xhaustively ag ainst Tris buffer (4
cha nges) , the protein sol ut ion was concentrated by ultra-
f iltration , and a liquots wer e s t ored at _20Ge . Pr otein
c on cen tration was measured by the method of Lowry e t al .
( 1951) u s ing eS A as s t andard . The pur ity of CRP was che cked
by e l ect r ophoresis and high performance liquid
c h ro matog ra phy (HPLC) . Pr e parations whic h gave a s i ngle band
on electrophores i s or a s ingl e peak on HPLC were used for
f urther studi e s.
4 ) . 'np.nUop of Millo Pfottip!!! Rat CRP (1 0 mg) was
de s!alylated by inCUbating with 0 . 5 i nter nationa l a ct ivity
units of neu raminidase in 10 ml of Tris buffe r at 37 °C f or 3
h. The i ncubation mi xt ur e was then ap p l ied t o a sepha ro s e -
pheny1pho sph orylchol ine atf i nit y column (2 e m x 3!5 em) . The
column was wa s h ed ex tens i ve ly with Tris buffer . Rat as i a lo
e RP boun d t o the colUllln was el uted with B mM pho sphoryl-
c ho line i n Tr i s buf f e r. AGP and fetuin were de s ialylated by
treating with 0. 05 M HZS04 at so- c for 60 min, f ollowing t he
procedure of spiro (19 64) . The a mount of s ialic ac i d
released dur i ng i ncubat i on a nd sia lic acid remaining on the
prote in was determined using t he method of Warren (1 959) .
Typically, de sialylation r esu l t e d i n the remo val o f >90", of
the s i a lic acid from r at eRP and AGP.
5 ) . RacHoiodinaUon Proc.dur81 Rat CRP, rat as ialo CRP,
r abbit CRP, AGP, and asia l0 AGP were iodinated with I odo-Gen
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iodination r e a gent as the catalyst following the
manufacture r I s procedure (Pier ce ) . Briefly , 2 mCi of carrier
free Na125I was di luted t o 60 ~l with 0 .1 N NaOH. rcdo- c en
coa ted t ubes wcre rinsed with Tris buffer . Pr otein s olution
in Tris buffer was then added , to a ratio o f 10 I-Ig
protein/I-Ig l odo-Gen, followed by 500 ~Ci Na12SI i n 15 ~1 of
0 .1 N NaOH. The reaction mix ture was l e f t at room
temperature for 1 0 - 1 5 min wi th occasiona l s haking, and then
app lied t o a G-2 5 column (20 ml bed v o lume) . whi ch had been
previous l y equilibrated with Tris bu tfer followed by 0 .5 ml
of BSA ( 1 mg/ml in Tr is buf f e r ) . The l abeled protein was
collected from the void volume and d ialysed against Tris
buffer . Samp l e s were aliquoted and stored at
-20°C. The specific r adioact i v i t y was i n t h e r a nge of 1.0-
1.5 x 10 6 CPM//Jg protein an d g reater t han 96\ of the
r ad i oa ct i vity was precipitable by ice-cold t r i c hlor oac eti c
acid (S\)-phosphotungstic acid (n) .
C. MfALYTI CAL PROCEDQRg0
1) . Electrophor esis Pr otein samp les were analyzed by either
na tive or 50S po lyacrylamide gel e lectrophoresis (Native-
PAGE, and SDS-PAGE) using t he separation u nit of a
Phastsystem (Pharmacia) and a -25\ g radient gels (Pha s t Ge l ,
Pharmacia) . After e lectropho resis, t h e gels were stained
with Coomassie R 350 dye (Pha rmac i a ) us i ng t he dev Qlopment
unit of the Pha stSystem .
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To determin J whether the iodinlltion procedure had
alte red the pro t e i n s , labeled protein sample was mixed with
a n equ a l volume of unlabeled protein. The electrophoresis
was run und er the same condition as wi t h un labeled proteins .
After sta i n i ng with Coollass!e blue R 350 dye , the ge l was
lIlanually cut into 2 -3 JlllI sections and counted. fo r
radioac t ivity i n a gamma counter. OVer 90\ of the
radioactivity appeared in the r e g i on o f the unlabe led
ereeedns ,
2 ) . BPLC ana l y d s HPLC was performed on a Perk i n-El mer
Series 4 HPLe system using a TSK- 250 gel fil t rat i on c o l umn
{JOO x 1 . 5 mm, are-aeer . r.l.'he co lumn wa s equi librat ed with 5-
10 be d vo l umes of 0.05 K Naz50, - 0 . 02 K NaHzPO, buffe r (pH
6 .8) a t ill flow rate of 1 .0 ml/min . A protein samp le
(containing 10 -100 1£9 protein in 10 -100 Ill) was app lie d and
the colulln eluted at a flow r ate of 1. a IIl /ain with t h e
equilibration buffer . The e luent was monitored at 280 nm.
The 125I _l a be l e d proteins wero analysed by HPLC to
determine wether iodination procedure had altered the
protein. Labeled p r ote i n s ampl e was mixed with an equal
volume of unl a be l e d protein. The lIixture wa s applied to the
c o lumn and e l uted as described a bove. The e l ue nt was
monit o red for its absorbance at 280 nm and for r ad i oa c t i v i t y
wi t h a Bec kman 17 1 r ad ioisotope det ector . Alte r native ly,
f r ac tions ( 0 . 5 ml) of the e l uen t were co llect ed and counted
tor r ad i oact i vit y i n a Beckman g amma 5500 c ount er. More than
.6
90t of the r ad i oac t i v i t y was eluted under the pe.tk for the
un labeled protein .
The following procedure vas used to analyze the
radioactivity associated with tissue homogenates (see part 0
ltiD....Yi..:i..Q experiments" for the preparation of t issue
homoqen a t e s ) after the injection of radioactive protein
samples. Al iquots o f 1 ml o f liver and lung ho mogenates wer e
transferred to Eppendorf t ubes . To release the bound
r adioac tivity from the tissu'c:t , EDTA solution (0 .12 ml, 100
lDM) was added . The total v ol ume ",as ad justed to 1 .5 ml wi t h
s a line . After incubating at room t emperature for 15 mi n , t he
samples wer e c entrifuged at 11 ,000 rpm f or 5 min . The
supernatant "'as filtered through a 0. 22 J£1Q filter and
ap plie d on an HPLC gel filtration colum n (Sphe r oge l-TSK, 7 . S
x 300 mm) , "'h i ch had been p~eviously equilibrated wi th
Na zSO, /NaH zP04 buffer (pH 6 . 8 ) . Tile f l ow rate was maint ained
at 1 .0 ml / mio . The eluent was monitored at 280 nm and
fractions of the e l u e nt were co l l c:o';ed an d counted f or
radioactivity in a gamma counter.
D. IN YlVO CLEARANce EXPERIMENTS
Rats vere anaesthetized with ether and a protei n s ample
(10 - 15 /-£g, a-IS x 106 CPM in 250 J£1 Tris buffer) was
injected through a tail v e in. The tip of the tall was cu t
an d blood scl.mples were collected at r egular time i n t erv a l s
into c ubes containing 50 pl of 10 jJ9/ pl heparin in saUne .
The volume of each blood s ampl e c o lle c t e d was measured.
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Duplicate aliquots of the blood samples (30 1-11) were taken
into counting vials containing 1.0 III saline and counted for
radioactivity in a gatnma counter . After the last blood
sample was taken, the remaining blood in the animal was
removed by perfusing through the vena cava with Hanks'
buffer. Liver, lungs , kidney, spleen, pancreas, thymus,
heart, stomach , and large and small intestine were removed,
rinsed with ice-cold saline, blotted dry, weighed, and
homogenised in ice-cold saline with a Polytron homogenizer
(setting 6, for 10 sec, x 3 times) . The total volume of each
homogenate was measured . Duplicate samples of 0.8 ml tissue
homogenates were transferred to Eppendorf tUbes containing
0.6 ml saline . After centrifuging at 11,000 rpm for 3 min,
the radioactivity in the supernatant and pellet of each
sample was measured in a galllllla counter. The radioactivity
associated with the pellet was taken as tissue associated
radioactivity . The radioactivity in each whole organ and for
per gram tissue was then calculated.
To determine the protein-bound radioactivity, 0 .4 ml of
tissue homogenate or 30 ~l of blood sample was inCUbated for
15 mi n at 0-4°C with 1 ml of ice-cold trichloroacetic acid
(SIl)-phosphotungstic acid (It). After centrifuging, the
radioactivity a ssociated with the pellets was counted for
radioactivity in a gamma counter. The radioactivity
precipitable by ice-cold trichloroacetic acid (5t)-
phosphotungstic acid (It) was taken as protein-bound
4B
radioactiv i ty .
E. LJ"8 P UlDUO" £JPlRlMEN'l'S
Rats were anaesthetized with ether and the abdominal
cavity cut opan . The l iver was then perfused t h r ough the
porta l vein with Hanks' buffer at 37°C, during which t ime
the liver was ex c ised free of other tissue and placed in a
r eservoir . The perfusion so lution was then changed to 70 ml
of Waymouth 's medium containing the l..lbe led protein sample
and recirculated a t 37°C f or 45 -6 0 mi n t hrough the liver at
a flow rate o f 30 ml/min . During the perfusion , t he solution
was constantly oxygenated with a gas mixture of 95\ oxygen
and 5% c a r b on d ioxide . Sampl e s of the perfus ate (0 .2 ml )
were taken at regular time intervals. At the end of the
exp eriment , the perfusion solution was changed to saline and
the l i ve r was briefly perfused to remove the r ema i n i ng
WaY1llouth l s med i um. The radioacti v ity in 50 u L aliquots of
the perfusate salllp les and in the liver was determined as
described earlier .
Effect of GalN Ac or phesphorylcholine on the c l e a r a nc e
of labeled r at asialo CRP and aslale AGP was studied by
i nc luding 8 1lIK GalNAc or 1 mM phosphorylcholine i n
waym.outh's med i um. When stUdying the e f f ec t o f neuraminidase
on t h e hepatic asialoglycoprotein r e ceptor , the liver was
f irst pe r f us ed at 37°C with 70 ml of Waymouthls medium
co ntaining 0 . 5 i nternational activit y units of neuraminidase
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for 30 min. The liver was then perfused with 30 ml of
Waymouth's medium to remove the remaining neuraminidase . The
perfusion solution was subsequently changed to 70 ml of
fresh waymouth I s medium containing 15 JJg of l a bele d rat
as Ie Io CRP or asialo AGP, and the liver perfused for another
45 t o 60 min . The radioactivity in the perfusate was
monitored as described earlier .
F . P RE U RAU ON or HE PATOCYTES
Rat hepatoc yte s were prepared by a modification of
collagenase perfusion procedure of Seglen ( 1973) . Male
sprague-Dawley rats (200-250 q body weight) were
anaesthetized with ether and the abdomina l cavity exposed .
The liver was then perfused t hrough t he po r tal vein with
calcium-free Hanks I buffer at 37°C. du ring which time the
liver was excised free o f other tissue and placed in a
reservoir . The perfusion solution was changed t o 120 rnl of
Hanks' buffer, containing 25 mg of c ol l a gena s e and 35 mg of
caClz·2HzO and re-clrcul a ted through the liver at a tIow rate
of 30 tnl/min f or about 10-15 min at 37°C. The perfusion
solution was constantly oxygenated with a ga s mixture of 95%
oxygen and 5% carbon dioxide . After pe r f us i ng with
collagenase solution, the live r was pl ac ed in a 100 nun Petri
dish on ice, rinsed with ice-cold Medium/BSA , t h en squeezed
gently by hand to release the cells. The ce l l suspension was
incubated a t 37°C fo r 30 mi n wi th 95% oxygen and 5% c arbon
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d ioxide as the g'as phase . subsequently , the cell sus pens i on
waa kept on i c e f or 10 min t o br inq t he t e mpe rature de,;wn t o
a _4°C, an d then fil tered throug'h 8 l a yers o f c be ese- c rce h t o
r emove cel l ag'greqates. The fil t r ate v as washed t hree times
by c entr ifug i ng at 5 0 xq for 2 min. The final cell pelle t
wa s r e - s us pe nded i n ice-cold MediWl./BSA. a nd t he cell
concent ration was de termined using a Levy Chambe r . Cel l
v iability, a s se s s ed by 0 .02\ t rypan blue ex c lusion , was
usually 80 -85\ . Hepatoc ytes with d iffer e nt viabi l i t y were
prepared by l ea ving t he cells in a hypot on ic buf f e r ( 2 6 111M
NaRCo,_ 0 .34 111M Na2HP0 4, 0 .44 mM KH2P04, o. a mM KgS04' 7H20 , ~L4
mH KCl , pH 7 . 4) fo r di f fe r e nt period s of time .
G. HEn-TOC"! BlNPXJfq MSUS
Bi nding as says were ca r ried out foll owing the procedure
described by Welge 1 (1980 ) but with certain mod if i c atio ns .
In order t o prevent i nt e rna l i za t i on of t he s urfa ce bound
proteins, ill t empe r atur e o f 40C was chosen i n the binding
assays . The b i nd ing at thi s t empe rature r ep r e se nts surface
b i nding (To llesha ug, 1981 ) . I n a typical bind i ng a s s ay ,
hepa tocytes (6. 5 x 105) a nd l ab ele d prote i n samp l e were
incubated i n 1 1111 of Me d ium/ BSA a t 4°C f or 90 min. The t u bes
used were pre-treated ....ith 0 .5 \ BSA fo r 1 h t o prevent non-
s pe c ifi c b inding to the wall of the tubes . After adding the
cell suspen sion , the t ube s were qa s s ed with 95\ oxygen a nd
5\ carbon dioxide mixture, a nd i 1lU'lledi ately s toppe r ed . Ce lls
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were kept in suspe ns i on by gently swirling t he t Ube s about
every 5 min. At the end of t he incu bation , the i ncubation
mixtures were firs t d iluted wi th abo ut e ight vo l umes of Ice-
co ld Kreb 's-bicarbonate/BS A bu ffer, then centrifuged a t
2.000 rpm for 2 min. After removing he superna t ant by
aspiration . the pe l l e t was ge nt ly suspended in 10 ml of ice-
cold Kreb ' s -bicarbonate/BSA and re-centrifuged . This
procedure was repeated twice . The tinal pe l let was
t r a ns f e r r e d into a Bio-Vial cO·J.nt inq vial, and counted for
radioactivity in a gamma count e r . The radioactivity
associated with the pe l let was taken as t he total binding .
Non-1;lpecific binding was determined by carrying out the
binding assays i n the pr e s enc e o f a lOO-fold excess o f the
un labeled protein o r in t he presenc e of 1 tnH ph os phoryl-
ch oline . For each concentration of the labeled protein, t he
specific binding wa s obtained by sUbtracting t h e non-
specific binding from t h e cor r e s pondi ng total binding . The
op timum cell concentrat ion and incubat ion time a t 37°C and
4°C was established by carrying out binding assays with
increasing ce ll concentration or di f f e r ent incubation times .
The optimum cell co ncentration c hosen was on t he linear
portion of binding curve, whi le the optimum incubation time
selected p roducer! maxit:lUm binding. The results of the
binding assays were reproducible a nd are r e pr e s e ntati v e of
at l e a s t t wo separate experiments.
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Chap t e r 3 M.I.llLUl
Section 1. BINDINg or MT A,BIALO CRr . RAT eRP
AND RABBIT eRP TO ISOLATED REPATOCYTES
Iso l at ed he patocytes hav e previously been us e d in
s tudies on the binding of a s ialoglycoprot e i ns to the hepat ic
asialoglycoprotein r eceptor (Mo r e ll e t a1., 1971 1 Ashwel l
and Harford , 1982 ; Weigel, 1980). To e xamine t he b i nd i ng of
g lycosylated CRP t o this r e cept or, the bi nding o f rat CRP
a nd rat as ialo CRP to isolated h e pat oc yte s was s t udied.
since mos t o f t he s tudies on the asia loglycoprotein recep tor
are based on t he b ind ing of as ialo AGP t o i s olated
hepatocy tes, t his protein was there f ore used as a posit i ve
co nt ro l in t his stUdy . Competitive i nh ibit i on studies o f the
b inding o f r at ea teac CRP and as ialo AGP t o the hepatocy t es
were carr i ed out in orde r t o determi ne if t he s e p r ote ins
bind t o t he same r ecept or on the he pa tocytes . In a ddition ,
the ef f ect of phosphor ylcholine and GalNAc on the binding of
r at as i a lo CRP and asialo AGP t o t he h epa t ocytes was
examined .
A . PQRITY &NP IDENTITY OF RAT CRP RAT MIALQ eRP aN p RABBIT
The pur ity of i so lat ed r at CRP and ra bb it CRP was
analyzed by HPLC us i ng a ge l 4!1 l tratio n column. I s olat ed rat
CRP gav e a single major pe ak Whic h accoun ted for mor e than
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95\ of t he tota l pe ak a rea (Fig. 5). A similar HPLC pro f ile
was obta ined with isolated rabbit CRP.
After neu raminidase t reatment, 93 \ of t he sialic acid
on r at CRP was removed. The resulting r at asialo CRP cross-
reacted with rabbit antiserum against rat CRP. It gave a
single peak on HPLC, and retained t h e phosphorylcholine
binding property , as was confirmed by i ts binding to
Sepharose-phenylphosphory1choline column (Fig . 6) .
B. 9RARACTERIZ&TIOH OF IlSI_LABELED PROTEINS
The 125 I_ labeled pr...."i;eins were ana lyzed on an HPLC
system wi th a Beckman 171 radioisotope detector. Fi g. 7
shows t hat the elution position of the 125I -labeled rat CRP
corresponds to that o f unlabeled rat CRP monitored a t 280
nm. Similar results were obtained for 125I_labeled r at asialo
CRP, rabbit CRP, and asialo AGP. Th e pu rity of the 1251 _
labe led proteins was a lso c hecked by e lectrophoresis on
native 8-25% gradient po lyacrylamide gels . In each case, t h e
125I - l abe l e d proteins had the same mobility as un labe led
proteins .
The labeled CRP bound t o Sepharose-phenylphosphoryl -
choline c o lumn and could be e luted with 8 rnM phosphoryl-
choline solution (Fig . 8) . Fractions of the e lutent was
co unted fo r radioac tivity with a Beckman gamma 5500 counter.
Greater t h an 95\ of the rad.i.oactivit y co rresponded t o t he
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Fig . 5 . BPLC profile ot bol_ted rat. CRP. A s ampl e of
isolated rat CRP in Tris bufter (100 ~1. 0.89 mg/ml ) was
applie d to a HPLC gel filtration column (300 x 7 .5 mID, 810-
Rad ) which had been equilibrated with 10 bed volumes ot 0 .0 5
M NaZso4~o . 0 2 M NaHzP04 bUffer (pH 6 .S) at a flow r at e of 1.0
Illi/min on a HPLC system (Perkin-Elmer Series 4) . The column
was washed a t a flow rate of 1 .0 ml / mi n with the
equilibration buffer and the eluent monitored at 280 nm.
This graph has been r ege ner a t ed by digitizing the elution
profile with sigmaplot program 3 . 1 (Jandel scientific).
55
1.2
1.0
g
D.•0
~
g 0••
~ 0.'
,ample 8mM
0.2 oprCotlon p-choline
1
20 40 60 80 100
Elution volume (m !)
120 140
Fig. 6 . Bindinq or rat aBialo CRP to • sepbarose-
phenylpbollpborylchol1ne column . Rat asiale CRP i n Tris
buffer (20 mI, 0 .74 mg/ml) was ap plied t o a 5epharose-
phe ny l phosphorylchol!ne co l umn (20 x 2 em) which ha d been
equ ilibrated with Tris buffer at a flow rate of 1 ml/m i n.
The c o lumn wa s was he d e xtens i v ely wi th Tris buffer unt i l
ab sorba nce a t 280 nm of the e l u en t wa s l e s s t han 0 .02 . The
bound rat a s i ala CRP was e luted wi t h 8 trIM ph osph orylcholine
in Tris buffer . Th i s graph has bee n r e gene r a t ed by
diqit idng the elution profile wi t h sigrnap lot p r og ram 3 . 1.
5.
Fiq . 7 . BPLC an al y . i . of 1Z5t·labde4 rat CRP .. nSI - labe led
r a t CRP i n Tri. bu ffe r ( 10 0 Ill , 0.1 21119/ 111) wa s applied t o a
HPLC gel f iltration c o l umn (3 00 x 7 . 5 _ , Bio-Rad ) which had
be en e qu ilibra ted ..... i th 10 bed v O!UlIles of 0 . 05 " Na2s04- 0 .02
H NaH2PO" buf f e r (p H 6. 8 ) a t a flow r ate ot 1. 0 ml /min on
perkin - Elme r , s e r i e s 4 , HPLC s ys t em. The c o l umn was was hed
a t a flow r at e o f 1. 0 m1/ min with the equ il i b ration bu t t e r.
Th e e l u ent wa s mon i t o r ed at 280 nm an d a l so f o r
r ad i oactivi t y wi t h a Beckman 171 rad ioi sotope detec t or. This
graph ha s bee n rege ne r ated by d igitizi ng t h e elutio n
prot ile s wi th sigmaplot progr a m 3 .1 .
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Fig . 8 . Bi a di nq of 1Zit-Iabeled r at. CR, t o a 8epbar os...
pbenylphospboryl cbolin. column. lUI-labeled rat CRP in Tr i s
buffe r (300 .ul , 0 . 12 mg/ ml) was applied t o a sepharose-
phenylphosphorylcholine column (5 x 0 .85 e m) which had been
equilibrated with Tris buffer at a flow rate of 0.5 ml / ain .
The c ol umn was washed extensively with Tris buffer until
abs o r ban ce at 28 0 nm of the eluent was l e s s than 0 .02. The
elution buffer was then changed to Tris buffer containing 8
Il'IM phosphorylcholine. This graph has been regenerated by
digitizing the elution profile with Slgmaplot program 3.1.
5.
phospho rylcholine -eluted pr ot e in peak. Therefore , iodina tion
d id no t affect t he phosphorylcholine bind ing p ro perty of
CRP.
C. ES 'l'ADLI S HH BNT Qr OP T I MUM CONDITIONS POR BINDING ASSAYS
1) . Requirement ot BBA to PreveDt tbe BiDding at 125I _ labele d
Pr oteins t o Gl ass Tubes
Di fferent conc e ntrat i ons of eS A were tested for t he i r
a bility to prevent t he binding at 12SI - l abel e d pr ot e i ns to
t he tubes . As show n i n Fig. 9 , t h i s b i ndi ng was dramatically
reduced when the tubes were coated with even O.OS\ of BSA .
2) . pe hrmi n a1;!on o t Optimua Cell Concentration a n d
tneubation Time (or Bind~
Th e total binding of asialo AGP i ncr ea s ed linear ly with
i nc r easing concentrations of hepatocytes (Fig . lOa) . The
total binding of rat CRP and ra t asial0 CRP also show ed a n
increase wi th increasing ce ll concent rations (Fig . lOb) . A
cell concentration of 6 . Sx lOs cells /m l was chosen for these
proteins , a n d used in t h e bind i ng assays .
From t he time c ourse of the binding of rat asial0 CRP
and rat CRP t o t he he patocytes (Fig . 11) I an i ncubation time
of 90 min was chosen f or the b i nd i ng assays .
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Fi g'. 9 . EU e c t of BSA OD the biDding of 125I _ l ab e l e 4 proteins
to the tub.a . Gl a s s t e s t tubes (6 x 50 mm) were immersed i n
0 .05% , 0 .2% or 0 .31 (w/V) BSA solution in Tris bu f t e r a t
r oom t emperature . Afte r 1 h, the tube s ....e re t a ke n out and
p laced upside down tor ab ou t :30 min to be a ir-dr ied . 125I _
labeled rat CRP (1 # 9 i n 0 .5 rol ot Med i um/ BSA ) was then
a dded to the t ube s , which were ke pt a t 40e f o r 90 ntn , After
being washed three t i mes with ICre b s buffe r . t h e tubes wer e
counted t or radioactivity 1n a 9amma counte r .
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Fig. 10 (a & b) . BiDding of 12SI_labeled 8s18lo AGP. rat
a.ialo CRP and rat ClI.P to isolated hepatocyte. a. a function
of hepatocyte concentrations. lZSI-labeled as i alo AGP (F ig .
acej , r at a sia l o CRP or rat CRP (Fig. lOb) (1 JJg, i n Tris
bu f t er ) wa s i nc u ba t ed wi th increasing conc e nt rations o t
hepatocytes (85\ v iable , 88% s ingle cells) i n 1 ml of
Medium/ BSA at 4°C for 60 mi n . The hepat oc yte s we re then
wa shed and c ounted f or r ad i oactivity as d escri bed i n chapter
2, pp , 51-5 2 . Each poi nt in the graph i s the mea n ot
dupl icate dete rmi na t i ons and i s r ep r ese ntative of t wo
sepa r a t e expe riments.
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Fig . 11. '1'i.8 CCluna of the bind inq o t' 125I _l abal ed r at CRP
and rat .lIialo cap to isol ated hepatocyte.. 125I-labeled rat
CRP or rat a91a10 CRP (l 1-19 , in Tris b Uf f e r ) was incubated
with 6 .5 x 10 5 he pa tocytes (85t viable, sst single cells) in
1. ml of Medi um/BSA at (DC. At t he Indi cat9d times , the
hepatocytes wer e washed a nd counted fo r radioactivity a s
described 1n c hapter 2, pp . 51-52 . Ea c h point in the g raph
is the mean of dupl icate determinations and is
representative of two separate experiments •
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D. BINDIN G 0' RAT &!IuLQ eRP RAt eRP AHP RABBIT eRP TO THI
HlnTOCttIl AI A ltlNCT:I O H o r PRQUIN COHCt NTMTI Q NS
The specific binding of asialo AGP t o the hepatoc ytes
....as saturable, ....hile that of AGP was negligible (F ig. 12,
i ns e rt) . Based on the binding of tlSI-labeled &Sialo AGP to
the hepatocytes, the number o f the hepatic asia l o -
glycoprotein r ecep tor s on each hepatocyte was calculated t o
be 8 . 6 X 104, which was compa rab le t o previously reported
val u e s (Table 3). These r esul t s a re con sistent with
observations i n ear lie r stud ies on the bind ing of es r ar e AGP
t o hepatocytes (Ashwel l a nd Harf or d , 1982) .
The amounts of t he specific binding of ra t asialo CRP,
rat CRP and rabbit CRP t o the hepatocytes, however , we r e all
much large r compared t o that of asial0 AGP (Fig . 12) . The
binding increas ed l i nearly within the range of p rotein
concentrations used in t h is s t udy . Betwee n 4- 7\ of the
protein added bo und to the hepatocytes . Th-. total binding of
rat CRP (Fig . l3b) and rat a s ido CRP (F ig. U a ) ....as reduc ed
by 70\ and 89', respec tively , in the preaence o f l OO-fold
exces s of un labeled protein. It is impor.t an t to note that
while the spcific binding o f ra t a sla10 CRP to the
hepatocytes was abo ut twi ce that o f ra t CRP, i t was over J O-
f old more than tha t of eefa r c AGP (Fig . 12 ) .
65
Fig. 12 . specific Bi Dding of r a t amial0 CRP, r at CRP, rabbit
CRP, AOP and a sialo AQP to iso l a ted hapatocytes as a
function o t protein con c:ent r ation s. I nc r ea s inq conce ntr a -
t ions o f 12SI-Iabeled AGP, e a t arc AGP (insert ) , rat CRP, r a t
asialo CRP, or ra bbit CRP were i nCl.lba ted with 6. 5 X 105
hep atocytes ( 9 0 ' v i a ble, 85\ single cells) i n 1 . 0 Illi o f
Med i um/BSA a t coc for 90 mi nut e s . The c ell bound radio-
activ i t y was determined as descr i bed i n chapter 2 , p~' . 51 -
52 . The non-spec if ic binding of 125I - I a be l ed AGP and asia lo
AGP was determined at ea ""h point by i n c luding loa-fold
excess of un labe l ed prote i n in t h e inc Ubat i on medium, while
the no n- s pecific binding o f m I - l abele d r a t CRP, rat aslalo
CRP or rabbit CRP wa s dete rmined in the presence of 1 mM
phosphoryl '~holine i n the incub a tion me dium . In t he case of
rat asialo CRP, rat CRP and r abb i t CRP, each point ha s been
obt ai ned by subt r a c t i ng the mean of t riplicate
determinations of non-specific b i nding from t hat of the
co rresponding t ot al b inding. The r e s ults s hown fo r thes e
proteins ar e r e pr e s e nt a t i v e of thre e simila r experiments. In
the ca s e of asi !\lo AGP and AGP. e ach po i nt h a s be e n ob t a ined
by sUbt ract i ng the mean of dup licate determinations of no n-
specific bind i ng f rom t hat of the corresponding t ota l
bind ing .
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Tab le J . Surface content of asialoqlycoprotein receptors on
bolated hepatocytes . The bind ing o f lzsI - l abe l ed asia l o AGP to
iso l a ted h epato c yt e s wer e carried out as de s cri be d it. '.he
leg end of Fi g . 12 . The number of asialog l ycoprotein receptors
on the isol ated hepatocytes ....as obtained by Scatcha rd a na lysis
of t he binding da ta (Fig . 12 , i n s ert ), an d based on the
assumption t hat the specific binding of ae I a Lc AGP represents
t he binding to t he hep a tic asialog lycoprote in receptor only,
and one mo l ecule o f a sial 0 AGP occupies one r e ce ptor .
"Quoted from Weigel a nd Oka (1983) .
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Fig . 13 (a & b) . Bin4ing of '251- 1aJ:uII1.4 r a t ad.lo CRP and
r at CRP to i s o1ate4 hepatocyte. a... function of protei n
concentr at i on s. The experimental details a re the same as
described in the legend of Fig . 12 , e xcept that t he non -
specific binding of 12S I - I abeled rat asialo CRP an d rat CRP
'Was determined by including r e o-se r a excess 0:' ., l a be l e d
protein in the incubation medium. Each point i n the graph is
the mean of triplicate determinations and is r e p r es e nt a t i vp
of two similar experiments. (TB: tota l binding ~ N53: non-
specific binding) .
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E . ?FlEeT or a.lNM l\ND PHOBPHORYLti flOLI NE ON THE BIND ING OF
RAT hBlhLO cap. BAT ca p l\ND RABBI T CRP T O THE REnT OC YTE8
In order to characterize the binding of rat as1a1o CRP,
rat cap and rabbit CRP to the hepatocytes , t he effect of
GalNAc and phosphorylcho line on their binding was examined.
GalNAc is a known inhibitor of the binding of a5ia 1o -
q1ycoproteins to the hepatic asialog1ycoprotein receptor
(Ashwe ll and Har ford , 1982). Phosphoryl c holin e is t h e ligand
that CRP b inds, and has been s hown to be involved in most
::RP related reactions ('renaea, 1967; Volanakis and Kaplan ,
1971 ) .
The binding of as IaLc AGP to the hepatocytes was
inhibited by GalNAc i n a dose -dependent manner (Fig. 14a),
whe reas the binding of rat asialo CRP, rat CRP and r abbi t
CRP to the hepatocytes did not change in the presence of
GalNAc (Fiq. 14a). I n contrast, phosphory1choline inhibited
(about 75\:) the binding of rat asialo CRP, r a t CRP and
rabbit CRP to the hepatocytes, but had not effect on the
bind inq o f a s LaLc AGP (Fig. 14b).
F . COMPE T ITIVE I NHIBITI ON ST UDIE S ON THE BI NDING or RAt
hSIALQ CRP , RAT CRP Nm ASULO AGP TO THE HE P ATOCYTfB
competitive inhibition is based on t he assumption t hat
if two proteins interact with t he same binding site, they
compete with each oth e r f or occupying t h at binding site.
When the hepatocytes ....ere pre-incubated with increasing
Fiq. 14 . Efrec~ of O. l JrfAo a nd pbospbory1cboUZle 011 ~be
bibdi bg of r.t. CRP. rat. uia10 CRP. r&bbi~ CRP abd a s ia10
AOP t o i.o1.ted h. p.tocyt .. .. 125I - l a be l ed r at CRP, r at i!lsialo
CRP, rabbit CRP or as1&10 AGP ( 1 P9, in Tri s bu ffer ) was
i nc uba t ed wi th 6 . 5 x 10 5 he pa t ocytes (85\ v iable , 85 \ sinqle
ce l ls) i n 1 .1 o f Hedium/ BSA a~ 4°C for 9 0 lI1in . Increasinq
co ncent r a t i ons ot GalNAc (Fig. 14a) or phosphoryl ch olin e
(Fig . 14b) were then added t o the incubation medium and the
ce l l suspensions were incubated for anot he r 15 min. Cell
bound r ad i oa ct i v ity was de termined as d e s c r i be d in chapte r
2, pp. 51 -52 . Th e amount ot lUI- l ab eled protei n bound in the
presence of different co ncentrat ions of GalNAc or
phospho ryl ch ol i ne ha s been expressed a s t he percentage of
t h a t i n the absenc e of Gal NAc and pho sphorylchol1ne . Each
point i n thi s grap h i s the mean t SEM o f three s epa r a t e
ex pe rille nts .
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concentrations of rat a5 ia10 CRP, the binding of lZSI -1abe1ed
asiale AGP to the hepatocytes decreased by up to 80 % in a
dose-dependent manner (Fig . 15) . In contrast, pre-incubating
the hepatocytes with rat CRP had no effect on the binding of
lzsI - l abe1 ed as Ie I o AGP to the he patocytes (F i g . 15) . These
results s uge;tes t that rat ee r a r e CRP binds to the hepatic
asia loglycoprotein receptor .
In another set of experiments , hepatocytes were pre-
incubated with rat asla10 CRP and increasing concentrations
of either GalNAc or phosphory1chollne . After the c e lls had
be en washed, 125I - l abe l ed asialo AGP was added, a nd the cell
suspension was further incUba t ed. The results showed that
GalNAc r e s t or e d the binding of lZ5I-labeled a sia lo AGP to the
hepatocytes pre-bound with rat asialo CRP (Fig. 16) . This
indicates that GalNAc releases r at asia lo CRP from the
hepatic aslalog1yc oprotein r eceptor, and confirms the
ir.volvement o f the e xposed galactose residues of rat a 5 i a l o
CRP in t h e binding of this protein t o the hepatic asialo
glycoprotein receptor . In contrast, phosphorylcholine did
not i ncrease the binding of 1Z5I - labe1ed asia10 AGP to the
hepatocytes pre-bound with rat a sialo CRP ( Fi g . 16) . This
shows that, although phosphory1choline release::: more than
7 5% of r at a s i.a Lc CRP from the hepatocytes (F ig. 14b), it
d id not r e l e as e any rat asialo CRP bound to the hepatic
asia1og1ycoprotein receptors .
When the binding of 1n I -1abe1ed rat asialo CRP to the
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Fig . 1 5. COlllpatit.iva inhitJ ition of t ha tJindinq a t 125I _ 1ab e led
a s ia10 AGP t o iso latad b epatocyta. by rat • • la10 c a p or rat
CRP . Increasing amounts of rat asial0 CRP or rat CRP were
incubated with 6 .5 x 10 5 hepatocytes (90\ viable, 85\ single
cells) in 1 ml of Medium/BSA at 4°C . Afte r 60 mi n, I /J9 of I2SI~
labeled eeIeLc AGP (in Tris buffer) was added to each t ube .
The cel l suspensions were i n c ubat e d for another 90 min at 4°C.
Ce ll bound radioact ivity was t hen de termi ned as described in
chapter 2 , pp , 51-52. Tho! amount of 12S I - Iabe1ed asialo AGP
bound to the c e l l s in the presence o f different concentrations
of either rat asialo CRP or rat CRP h a s been expressed as the
percentage of ""ha t in the absence of rat asia10 CRP or rat
CRP . Each point i n this graph i s the mean of duplicate
determi na tions and i s representative cr two similar
experiments.
Fig. 16 . Effect of Oa l NAc and phosphorylcholine on t he
co mpetit i v e i nhitJition of the biD ding o f IZ5I - I a.be led asia10
AOP b y r a t ada10 CRP. Rat asialo CRP (300 jJg in Tris buffer)
was incubate.d at 40C for 60 min with 6 .5 x 105 hepatocy tes (90t
v iable, 85% single cells) in 2 ml of Medi um/BSA in the
presence of 8 Mm GalNAc or 1 mM phosphorylcholine . The cells
we r e t hen washed twic-e with Me di um/ BSA and re -suspended in 1
ml of Medium/BSA . 125I_labeled asialo AGP (1 ~g i n Tris bu ffer)
wa s added to each tube, and t he c e l l suspensions wer e
incubated f or another 90 min at 4°C. The ce ll bound r a d i o-
a c t i v i t y was determined b. :\ described in chapter 2 , pp. 51-52 .
The amount of 125I - I abel ed asialo AGP bound t o the ce l l s after
the t r ea t ment wi th different concentrations of either GalNAc
or phospho,,:ylcholine has been expressed as the percentage of
that i n the absence o f rat aedatc CRP, GalNAc and
:,h os phor y1chol i ne . Each point in this graph i s the mean o f
d up l i c at e determinations and is r e pr e s e nt at i ve of two separate
e xperiments .
(Fog.15)
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0.0 3 .0 6.0 9 .0 12 .0 15.0
(Fig. 16)
100 . ' --- ~-
"- ----
e-. + rot CRP
0-0 + rot ceiclo CRP
CL
o
<!
o
o
'iii
o
I
~~
-0
C
::>
o
.o
~
80
60
40
20
\
\,
"-0-"-------0
100
80
60
40
20
o_o~o
/ 0/ 0 -0 + GalNAc
o 6-6 + P-choline
", /"'---", '"
---
o I , I
a 20 40 60 80 100
excess (fold) of unlabe led protein
a I , '
0.0 0 .4 0 .8 1.2 1.6 2.0
P-choline (mM)
he pa.tocytes was carried out in t he pre e enc e o f inc r easing
concentrations of r at CRP, there was a do se -dependent
decre ase of the binding of 12SI - l abe led r at eeaarc CRP to the
hepatocytes (Fig. 17 ) . On the other hand, AGP had no e f f ec t
on the binding of 12SI_l a be l ed asido AGP to the hepatocytes
(Fi g . 17 ) . This i nd i cat e s that , i n addition to its binding
t o the he pati c a s ialog1 yco prote in rece ptor , r at a s ial0 CRP
s ha res with rat CRP a common binding site on the
hepatoc ytes, which i s di fferent from t he he pa t i c
as ial og lycoprot ein r eceptor .
G. BIHPlJiG Qr BAT MULa CRr TQ XBQUTEP RJiP&TOCYTIB WITH
DIFFERENT VIUILITY
It ha s been su gg ested that t he binding o f ;::R.P t o cell
membranes requ ires a d isr up t ion of t he s t ru c t ur e o f the
membranes (Volanak i s and Wirtz, 1979 ; Nar ka t e s a nd
Vol ana kis, 198 2) . In order to prov ide a rat i o nal explanation
f or the av id binding of CRP t o t he he patocytes ob served in
t his s t Udy , hepatocytes with different viabil i ty were us ed
i n the b inding ass ays . JI•a shown i n Fig. 18 , there was an
increase i n the binding of r at aera t e CRP to he.patocytes
with decr ea sing viability.
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Fig . 17. competi tive I nhib i tion of the biDd ing o t: 1251_
l abeled r at a sia10 CRP and a.la 1 0 AGP t o illo lated
he p atocyt •• b y rat CRP and AGP. lUI-labe led rat asiale CRP
or asl a lo AGP was incubated with 6 . 5 x l OS he p a t ocy t es (85%
v i able , 85% single cells) in 1 ml of Medi um/BSA at 4°C for
90 mi n in the presence of increas ing amounts of rat CRP or
AGP. Cell bound radioactivity was de termined as de ecrIb ed in
chapter 2, pp . 51- 52 . The alliount of 12SI-l abeled as lalo AGP
or rat aslalo CRP bo und t o the cells i n the presence of
different concentrations o f unl a be l ed proteins has been
expressed as the percentage o f that i n the ab senc e of
un l abe l ed proteins . Each point i n the graph is the mea n
± 2 SO o f two separate expe r i me nt s .
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Fig. 18 . p inding of 125I _l ab 8le4 rat aslalo CRP to !aolatad
hepatocyt8s wi th 4it' f erent viability. 12SI-labeled r at a siale
CRP (2 /l g. in Tris buffer ) was incubated for 70 min with 1.0
x 1 06 hepatocytes with 8 6%, 74 \ or 65 % v i a b il i t y in 1.0 ml
of Medium/ BSA. 'rh e c e l l bound r adioacti vity was then
det e rmined a s de s cribed i n cha pt e r 2, pp . 51-52. The data
s hown in t his graph is the mean ± SEM of triplicate
de t erminations .
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Section II . CLEARlt.NCB or BAT M I ATO CRP, RAT CR!
AND RABB IT CRr I N VIVO NIP BY P ER U SED LI VER
In section I , the binding of rat aslalo CRP, rat CRP
and rabbit CRP to isolated hepatocytes was s t udied . Large
amoun ts of binding of these CRP to the hepatocytes were
observed . This binding was i nhi bit ed by phosphorylcholine.
The binding o f rat asialo CRP to the hepatic asialo-
glycoprotein receptor could be shown on ly indirectly . In
this se ction , the 1n.....Y.i.Y9. clearance of CRP was s t ud i ed i n
order to determine a) . if t he phosphorylcholine binding
domain of CRP i s i nv o l ved in CRP' s .1.n.....Y.UQ c l e ar anc e,I bj , if
rat aslalo CRP is cleared t hr ough Ashwell's pathway; and c) .
if non-hepatic tissues are i nvolved i n the clearance of
these proteins .
A . CLEARAN CE o r 125I_UBELE D RAT AS IA LO CRP , RAT CRE AND
RABBIT e R E IN RAT
Rat asialo CRP a nd eexaie AGP we r e r api dly removed from
circulation (Fig. 19) . Fou r min a fter the injection , about
50% of r a t ae La Ic CRP and mor e than 90% of asialo AGP were
cleared from c i r cul a t i on (Fi g . 19). In con trast , the
radioactivity a s sociated with 125I_I abeled AGP and r abbit CRP
remained in circ ulation for over 3 hours (Fig. 19 ) . The
cleara nce of rat CRP was examined fo r 28 hou rs . The half-
life obtained was about 7 .8 hour , which is much longer t han
'0
Fi g. 19 . ClearaDce of rat ••ia10 CRP, aDd rat CRP and rabbit
CRP fro. ciroul.tiob. 125I - 1a be led protein samp l e (IO-IS jig,
8- 15 X 106 CPH, in 250 jil of Tris bu f fer ) was i njected
t hr ou gh the t ail vein . The radi oactivity i n bloo d s amples
was determ in ed as described in chapter 2, pp . 47-48. The
amount o f radioa ctivity 1n blood samp l es collected at
different t i mes h as b e en expressed as t he pe rce ntage of that
in t he first b lood s a mpl e . I n the case o f r at a sialo CRP,
ea c h point is t he mean ± SEM o f three sepa rat e experiments .
In t he case of rabbit CRP, each point 1s t he mean ± 2 SO of
two separate ex periments . I n t he case of ra t CRP, the
experiments were ca rr i ed out in 5 r ats , ....hich ....ere
sacrif i ced at d i f ferent times . Each point i n t he graph
r e p r e s en t s da ta obtaine d f rom one r at .
% in circ ulati on
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its desia lylated derivative (Fig . 19 , insert) .
B. CQMPIiT I'l'I VI nfHIBITION QF T8 1 1M VI VO g LURANCE OF RJ.T
~SULO CRP BY nnw " OP MULQ-FETUIN ANp AGP
When 125I - l a be l ed rat asialo CRP was i n j ec t ed wi th
increasing amounts of asialo AGP, a dose-dependent
inhibition of the c learance of lZSI - l abel ed rat a5 ialo CRP
was observed (Fig . 20) . A 60-fold excess of asialo AGP ove r
125I _l abe l ed rat aslalo CRP partially inhibited the clearance
of lzsI - l a bel ed rat ae Lafc CRP, whi le a aoo-rera excess of
asialo AGP completely i nhi b i t ed t he c learance . Sirnilarly,
the addit ion of a J OO-fold excess of asia lo-fetuin al s o
resulted in a nearly complete i nhibition of the clearance of
125I - 1abe l ed rat a5 1a10 CRP (Fig. 21). In contrast, over
1, CCO-f ol d excess of AGP had nc effect on the clearance of
125I-labeled ra t asf.aLc CRP (Fig . 21).
C . DUl TRTBUTJ ON OF RADI OACTIVITY IN TISS UES FQLLO WING THE
CLE~RANCE or IZ5I_LABELED RAT 1811\1.0 CRP , RAT e RP AND R1r.BBIT
The distribu tion of r ad i oact i vi t y in liver, l u ngs ,
kidney, spleen, stomach, t hymus , h ea rt , bone marrow ,
pancreas and intestine was examined after the injection of
lzsI - l abe l ed rat as1alo CRP, a 81a10 AGP, rat CRP and rabbit
CRP ,
I n the case of lzsr-l a ba l ed rat asia10 CRP, the h i ghe s t
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F i g . 20 . competitive inhibition of the charanee of
1ZSI - labeled rat aai.lo CRP by aaialo AGP. 12.SI-labeled r at
asial0 CRP ( 15 1-'9, 1.1 x 1 07 CPM, i n 250 1-'1 o f Tris bUffe r)
was i njected into the t ai l ve i n along wlth 3 00 I-'g (60 -fcld
excess), 750 1-'9 ( ISO-fold excess) or 1 , 500 Ilg (aco- rere
excess) of e e tai.c AGP. Th e r ad ioactivity in bloed samp l es
c o llect ed at d if fere nt t i me was determined as desc r i bed in
chapter 2, p p , 401-4 8 . The pe rcentage o f radioactive labe l i n
c i r cu l a t i on at different t i me s was calculated a s d escr i bed i n
the legend o f Fig . 1 9 . For the c lear ance o f r at as ido CRP i n
t h e ab sence o f asialo AGP , each po i nt i n the graph is t he
mean ± SEM of three separate experiments. For t he clea rance
o f r at as l alo CRP in the p r esence of 60-fold or J OO-fo ld
excess of ae Lajc AGP, each poi nt is the mean t 2 S O of t wo
s e par a t e experi ment s .
F ig . 2 1. competitive inhibition of the clearance of
1zsI_labeled rat as ialo CRP by a s ialo-fetuin or AGP. m I _
labeled r a t ds- CRP ( 15 1-'9 , 1.1 x l OT CPM, i n 250 III of Tr i s
buffer ) was inj ect e d into t he t a il vein a long wi t h 1. 8 mg o f
as ialo-fetuin (JOO- fo ld e x ces s) or 5 Ing of AGP (lOaO-fold
excess) . The r adio a ctivity in blood samples co llected at
di f f er ent time was determined as descri bed i n chap ter 2 , pp .
4 7-40 8 . The perc entage o f r ad ioac tive l abel in circulat ion a t
differe nt times was calcu lated as described i n t h e lege nd o f
Fig. 1 9 . Con trol refers to the clearance o f 125I - l a be1 e d ra t
asla lo CRP in t he abs en c e of asialo-fetuin o r AGP. I n the
case of c ontrol group , e a c h po i nt i n the g r ap h is the mean ±
SEM o f t hree separate ex periments . For t he c l earance of ra t
asialo CRP in the pre sence of AGP or asia l o -fetu i n , ea ch
p oi nt i n the graph i s the mean ± 2 SO of t wo s ep arate
e xpe riments.
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radioactivity (pe r gram t i s SU9) was tound in the liver ( Fig .
22 ) . The recovery ot r a d i oa c tiv i t y associated with r a t
aslalo cna, rat CRP, rabbit CRP a nd alJ1al o AGP is listed in
Table 4 . The high recovery of t he radioac tivity in t he live~
assoc i at ed. with lzsI _la beled r at; asialo CRP was s bilar to
that associated with lzsI - 1abe l ed asido "GP. On t he othe r
ha nd, only small amounts of r adi oa ct ivity associated with
llSI -labeled ra t CRP and ra bbit CRP were r ecove r e d i n t he
liver . As shown in Fi g . 2J a, t he radioactivity in the liver
de c reased r ap i d l y with time.
Some ra dioactivity associated with lzsI-labeled ra t CRP,
ra t asia l o CRP and r abbit: CRP was a lso r ec ove r e d in t he
l un gs (Table 4 & Fig . 2Jb). Here , the r a d i oact i vity did not
change wi t h time for up to 60 min . Howeve r , after 180 min ,
there was a r e d uc tion o f r a d i oac t i v i t y i n t h e lung'S in the
case of 125I - l abeled rat aslalo CRP and r a t CRP (rabbit CRP
was not examined at 180 mi n ). In c ontrast, no r adi o act i v i t y
associated with either 125I-labeled AGP or as i alo AGP was
detected in the lungs (Tab l e 4 & Fig. 2Jb) .
In the compe tition inhibition experiments of t he
clearance of llSI-lab e led ra t asialo CRP by asialo AGP (Fig.
20 ) , the r e covery of r adi oa c t i v i t y in live r and lu ngs was
ex amined . I n the presence o f i nc reasing concent ra t ions of
as ia10 AGP, the r ec overy of r ad i o ac tivity a s s ociated with
lzsI - labeled rat asia l o CRP i n liver dec reased (Fig . 24) . At
the same t ime, t he rad i oacti vity associated with 125I _Iabe led
8.
Fig. 22 . 'rb8ue 4ht.ribut.ioD of :n4ioaot.!vit.y 20 miD .ft.er
t.he injeot.!on of 125I-labele4 rat adalo CRP . Twenty min
after the injection of 12SI - 1abe 1ed rat asia10 CRP (12 1-'9, 9
x 10' CPK), radioactivity in different tissues was
determined as described in chapter 2, pp . 47-48. Results
shown were obtained from two separate experiments . Error
bars in the graph represent the confidence limits with 95'
probability.
.7
Conditions rat rabbit eeLatc
e edarc CRP rat CRP CRP AGP
CPM inj ected
(xl06)
• c leared f romcirculation 92 ± 3 .1.\ 6 ± 2 .7\ 5 :t 2 .3% ' 0 ± 4 .2'0
after 20 min
CPM recovered 7 . 1 ± 1.3 0 .3 ± 0 .1 0.3 ± 0 . 1 6 .' , 1 . 2
in liver (Xl 06 )
Reco very of
c l e are d 86 t 14% 60 , 16% 65 ± 2 2% 85 ± 1 5 %
radioactivity
in liver
CPM re c over e d 6 . ' ± 2 .7 6 .4 ± 1., 1. ± 2. 4 0 .5 ± 0 . 1
i n l unq (xlO')
Recovery of
c leared 0 .8 ± 0 .3% 12 :t 3 .6t 30 ± 5.l\; 0 .05 ± o.on
radioactivity
in lung
Tabla 4. Reco ve ry of radioactivity in liver and lung-B. Twent y
mi n after the in jection of ,zsI-labeled ra t asLaj.c CRP, rat CRP ,
rabbit CRP and aslal0 AGP, radioactivity in l i ve r and l ungs was
de t e m i ned as described in cha pter 2. pp . 4 7- 48. The va lues in
this table are the means and their confidence limits with 9 5\
possibility .
8.
Fig . 23 (a " b ). Tiae- depelU1e Dt distribu tlofl o r
radio&otivity 1n U v.r aDd lUDq • • At 20 min, 60 min or 180
min after t he i n j ec tio n of Int -labeled rat asia lo CRP, ra t
and rabbit CRP, AGP or asialo AGP (9 x 10' CPH) ,
ra dioactivity in live r (Fig. 23a) and lungs (Fi g. 23b)
dete rmined. as de scribed in chapter 2, pp . 47-48 . Results
sho ....n ee r e obta ined f roll two s eparate ex pe rim ents (fo r " CP,
t he results were obtained f r o. one e xperi ment) . Error bars
i n the g raph r e pr es ent the c o nfid en c e limits with 95 \
probability.
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Fig. 24 . Bfte Clt of . d al o AtiP Ob tbe diatri ))utioD o f
r ad i o activity alil8oc h te4 " i t b IzsI-laha led r a t asia10 CRP in
l iver aDd lungs . Twenty min after the injection of 15 p.g of
125I-Iabeled rat asialo CRP and e ither 300 /Jl) (60 -fold
excess) or 1.5 mg (300-fold excess) of as1a l0 AGP,
radioactivity in liver a nd l u ng s was determined as described
in chapt er 2, pp . 47-48 . Control refers to t he distribution
of radioactivity 2 0 mi n after the inj ection of l25X- labe l ed
rat a slalo CRP i n the absence of aslalo AGP. Results shown
were obtained from two separate exp e r i ment s . Error bars i n
the graph represent t he confidence limits wi t h 95 \
probabil ity .
s i
rat a e.tarc CRP s howed an increase in lungs (Fi g . 24) .
D . HELe NfALYlU or DB IW)IOACTJYJ'l'X IN LID. N.P....Llllnl
HQMOQI!!HATB8
In order to de termir,ol! if there was an y degradation of
t he i njected 1Z5I-lab eled rat a s ialo CRP in live r an d lungs ,
the r adioa.c t i vity bo und to the liver and lungs was rel ea s ed
by EOTA treatme nt and a na l y ze d by HPLC using a qel-
f ilt ration col umn. Typic ally, EDTA treatment resulted in the
rele a se of >50% of the radioactivi ty f r om the t i s sue. When
t he superna tant obtained a f ter EDTA treatm en t of t he l i vel;"
an d l un g h omoge nat e s was ap pl i ed to the co lumn , ab ou t 20- 30\:
o f t he r ad i oact i v i t y e l uted at a p osition which co r respon do d
to intact rat asla lo CRP. A sma ll pe ak (about 1 0\: o f the
t otal a r e a ) ap pe ar ed at an earl i er t ime (7 min ) , whi ch may
represent aggr egated rat ilsia lo CRP. The r ema ining 60-70 \:
eluted at 1 5- 18 min, which c ould be due to s ome low
molecular we i ght f ragm e nt s (Fig . 25 a & b ) . This indic a tes
that the major i ty o f the rat asi alo CRP was deg r aded in
liver and l ungs , Assuming that EDTA tre atment o r
homoge n i zati on o f t he tis su e s d i d not contributed t o t he
degradation o f rat as i a l o CRP .
E. C LEaRANCE J!!XPERrMEH'l'R DR I ll G PIRPOBBD LIVER
The c l ea rance of r a t CRP and rat a s i alo CRP was f urther
studied us i ng perfused liver. The results c.bt aine d in thi s
sy stem ....e r e co mparable t o that observ e d in Whole an imals .
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Fi g . 25 (a and b) . HPLC protihs ot t be radioactivity
r elea s ad frolll l iver alld lunq bOlDoqea a tes , Homogenates o t
liver (Fi9. 25 a) a nd lung s (Fig . 25b ) obt a i n ed 20 min a tte r
the inj ection ot ) 0 1-\9 ot l ab eled rat aslal0 CRP wer e
treated wi t h 8 mH EDTA . The rel eased r adioactivity was
analyzed by HPte as descrIb ed i n ch a p ter 2, pp . 46-47.
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liSI-labeled rat 0.510.10 CRP and a8ialo AGP were cleared by
the perfused liver, while l25I-labeled rat CRP remained in
the perfusion medium during the procedure which lasted for
60 min (FI g. 26).
The hepatic asialoglycoprotein receptor is known to be
a glycoprotein whose terminal s i a l i c acids are involved in
the clearance of asialoglycoprotlilins (Ashwell and Harford ,
1982). After the perfused liver had been treated with
neuraminidase, the clearance of rat ae LaLc CRP was
completely i nh i b i t ed (Fig . 27) .
When GaINAc, a strong i nh i b i t or of the binding of
asialoglycoprotein to the hepatic asialoglycoprotein
receptor , was included i n the perfusion medium, the
clearance of l2SI-labeled rat esIeLc CRP by the perfused
liver was i nhibited (Fi g . 27).
To examine if the phosphorylcholine binding domain of
rat asialo CRP had any effect on its clearance , phosphoryl-
choline (l lIlM) ....as included in the perfusion medium . No
inhibition of the clearance of l25I _l a be l e d rat e erarc CRP
was observed (F ig. 27). One mM phosphorylcholine has been
shown previously to be more than SUfficient to inhibit the
binding of rat asialo CRP to Sepharose-phosphorylchol!ne
affinity column (Nagpurkar and Mookerjea, 1981).
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Fig . 26 . Cl••r ance of rat •• i a l 0 CRP, r at CIlP and • • ia1 0 l\GP
b y pe r ru• • '" liver . Rat l i v e r wa s perfused through the porta l
vein with oxygenated Hanks ' buffer at 37°C for 5 min as
described in c hapter 2, pp . 49-50 . The perfusion so lution
was then c ha n g ed t o 70 IlI of Wa ymout h I s medium containing 15
p.g o f llSI _I a b e l ed protein samples and rec irculated . The
liver was pe rfused for 60 min at a f low rate of 30 ml/min .
At the specified t i me interval s, a sample o f the perfus a te
was taken and the radioactivity in t h e pe rfusate de tet1llined
as described i n chapter 2 , pp . 49-50 . The amount of
radioactivity in t h e pe rfusate at different t imes has been
expressed as t he pe rcentage of t hat at 0 t i me . In the case
of rat CRP and rat a e rate CRP, each point in the graph
represents t h e mean ± 2 50 of t wo va lues from two separ ate
experiments .
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!Pig . 27 . Effect. of GalNAC, pbospborylobol1ne an d
neuraminidase o n tbe cle arance of rat &.ialo CRP by perfused
l iver. I n expe riments t o study the effect of Gal N1.c and
phosphorylcholine o n the cle ar ance of r a t asialo CRP. i!I
final conc entr a t i on of 8 JllM Gal NAc or 1 mM ph osph oryl cho l1 ne
vas i ncluded i n the perfusion mediu.. , to stUdy t h e effect of
neu raminidase o n the clearance o f rat a sialo CRP, the l i ve r
was fi r st perfused with waymouth'. lIed i um con ta ining 0.5
units of neu ramin idase fo r 30 mi n , fol l owed b y pe rfus!nq
wi th 30 ml of fresh Waymou t h 's med ium to r emove t he
ne uramini das e . The live r wa s t he n pe rfused with 70 ml o f
fresh Wa ymouth ' s medium c onta i ning 15 J!g of labeled rat
asido CRP. Ot he r experimental details and calcUlations a re
the s ame a s des cribed in the l eg end f or Fig . 26. Cont r ol
r e f ers to the c le aran ce o f r at asi alo CRP by the perfu s ed
liver in the absence of Ga lNAc , phosph o rylchol1ne or
ne uramini dase . Each po i nt i n the graph is the mean :t 2 SO of
two s epa rate experiments.
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Chapter 4~
Th e ob j ective ot this study was to exa.lne the
c l ear a nce mec ha nism o f CRP. Based on Ashwel l ' 5 observat ions ,
i t i s reas onable t o s peculat e that glycosylated CRP, afte r
de s ialylation, wou ld be taken up by the hepatocytes t hrough
the hepat i c. as i al og l ycoprot e i n receptor . Th i s study
demonstrated the c lea r anc e ot glycosylated CRP through
Ashwell's pathway a nd e xamined t he r ol e ot the phosphoryl -
choline binding ~omain of bot h glycosylated an d no n-
g lycosylated CRP i n t he ir c l ea rance .
A . BINDING or RAT UULO eRP . RAT CRP UP RABBIT CRP TO
IBOLATED HEPATOCYTES
The binding of asia lo AGP to isolated hepatocytes v as
s a t ur ab l e , a nd was inhi b i t ed by GalNAc (Fig. 12 , i ns ert and
Fig. 14a) . Bas ed on the binding ot asialo AGP t o t he
hepatocytes , the nu mber o f t he hepat i c llshloq lycop ro t ein
receptors on the surface of the hep atocytes v a s found to be
compa r a bl e v i th published r esu l ts (Table 3) . Therefore , i t
vas co nclUded that the as ialoglycoprotein r e c e ptor s on thes e
hepatocytes wer fJ functional .
However , i t vas observed that the binding of both rat
asia l o CRP a nd r a t CRP t o the h epatoc y t e s was much h i ghe r
t ha n that o f asialo AGP (Fig . 12) . The amoun t of r at as iale
CRP a nd rat CRP bound t o the hepatocytes vas 35 and 15
9.
times, respect ively, more than th",t o f 45i"'10 AGP (Fig. 12 ) .
Although the binding of ra t asialo CRP was about twice that
of rat CRP (Fig . 12) , the i ncrea s ed binding o f rat as ialo
CRP coul d not be attributed to the binding of this protein
to t he hepatic aslaloglycoproteln receptor , since Ga lNAc did
not reduce the binding of rat asialo CRP to the hepa tocytes
(Fig. 14a) . Consequently , it was r ea s ona ble to believe that
rat aafe Lc CRP did no t bind to t he hepatic as La rc-
glycoprotein receptor , and glycosylated CRP might be an
exception to Ashwell 's pathway.
The increased binding of ra t as Lato CRP t o the
hepatocytes, over that of rat CRP, can ee attributed to t h e
enhanced accessibility of t h e aslalo protein t o the binding
s ite, as a consequence of the reduced ne t negative charge
after desialylation . A similar observation was made during
the binding of human CRP to red blood cells. The binding of
human CRP to desialylated red blood cel ls was a bout twice
over that to normal r e d blood ce l ls (Volanakis, 1982a) .
In v iew of the common phosphorylcholine binding
property of CRP, the effect of ph osphor ylchol i ne on the
binding of r a t asIalo CRP, rat CRP and rabbIt CRP t o
hepatocyte vas examined . Phosphorylcholine inhibited the
binding o f t he s e CRP t o the hepa t ocyt es , but h ad no effect
on the binding of asialo AGP (Fig . 14b ). It was therefore
concluded that t hese CRP bound t o a common binding site on
the hepatocytes t hr ou g h their phosphory lchol i ne binding
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do ma i n . Additional s u p por t of t his concept wa s prov i ded by
t he competitiv e inhibi tion o f t he bind i ng of l a be l ed ra t
asia lo CRP t o the hepatocyt es by rat CRP. I n the pr e s e nce of
r at CRP. the binding of labeled r a t a slalo CRP t o the
hepatocy tes was reduced by a bout 60t (Fig. 17 ) .
The above resu lts , however , c ould not explain why
asia l o CRP had no interact i o n wIt h the hepat ic es r aro -
g l ycoprotein r e c ept or . One reas on cou l d be t h a t in t he
presence of lar ge amount s of phosphorylc hol i ne - med iated
bi n d ing o f rat asialo CRP to the hepatocyte s , t he b i nd i ng of
rat as lalo CRP to t he asla l ogl yco pr otein r eceptor could not
be detected. This poss ib ilit y was examined by compe titive
inh ibit i on studies using rat a s la l o CRP and asialo AGP.
Hepatocytes were pre-incubated with r a t asialo CRP be f ore
the ad dition of labeled asLej.e AGP. The r esults sho....ed that
the binding of l abe l e d as ia10 AGP was r educ ed by as much aa
80\ by r at astalo CRP pre-bound t o t h e he pa t ocytes (F i g .
15) . In co nt rast , p r e -incubating the hepatocyte::> wi th r a t
CRP had no effect on t he b inding of labeled asialo AGP (F i g .
17) . These r e sults demonst r ate that the ex posed galactos e
r e sidues o f r at asla l o CRP are r e spon s ible fo r t he
inhibition of the binding of asial o AGP to the he pa t ocy tes ,
a nd t hat rat asialo CRP binds t o the asia l oq l yc opr ot ein
r eceptor on the he pa t o cyt es. It was a lso s hown that when
hepat ocyte s Wh i c h had been pre-incubate d wi t h r at a s Iej.c CRP
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....ere treated wi th GalNAc , t he binding of labeled asialo AGP
to the hepatic asialoglycoprotein r eceptor was restored
(Fi g . 16). This indicates that r at asia I e CRP bound to the
hepatic asialog1ycopro tein receptor can be released l.t,.
ceraxe, and that the binding of ra t asialo CRP t o this
receptor is reversible .
I n order to determine if the large amounts of bi nd i ng
of r at a5 ia10 CRP t hrough its p hosphor y l c ho line binding
doma i n cou l d also be responsible for the compet itive
inhibition of asialo AGP binding , hepatocyt es we r e pre-
incubated with rat es r a a c CRP and t r ea t ed with phosphoryl -
choline . The binding of l a bel e d asiale AGP to the
hepatocytes was virtual ly unchanged with this treat ment
(F ig. 16) . On the other h a nd , phosphorylcholine has been
shown to reduce the binding of rat aslalo CRP by as muc h as
75%; (Fig . 14 b) . These results indicate that t he b i nd i ng ot
rat asiale CRP through i ts phosphorylcholine binding domain
I s d i s t i nct f rom its bind ing to the hep at i c as La Lo-
g lycoprotein r e c ept or .
A r ational explanation for the failure to directly
observe the binding of rat as La.Lc CRP to the hepatic
asia1og1ycoprotein receptor is that the phosphory1chol!ne
involved bindinq s ites on t he isolated hepatocytes far out-
nUmber the hepatic asialog lycoprotein r e c e pt or s. Under t h£'
ex pe rimenta l conditions used, i t is not possible to de t e ct
1 01
the much s maller amount of binding of r at asla l o CRP to the
hepatic aslaloglyc oprotein receptor .
To expla in the obs e rved large allounts of b inding of CRP
t o t he isolat ed hepatocytes , b i nd i ng assays using isola ted
hep atocyte s with d iffere nt viability were carried ou t . As
the viability of the hepatocytes decrease d, t h e binding of
r at asialo CRP to the hepatocytes i ncre as e d (Fig . 18 ). It is
assumed here t hat there i s a correlation between reduced
cel l viabil i ty an d greater disruption of the c e ll surfa c e .
It c a n be spe cu lated that disrupt ion of the hepatocyte
s ur f a ce generate s binding sites c ont a i ni ng the phosphoryl-
cho l ine ligand. Severa l examples a re a vailable i n the
literature I n suppor t o f this concept. i) Human CRP ha s be en
sho wn to b i nd more av id l y to a rtitic ia l bilaYQr membr anes
tha t have been s t ruc t urally altered (Volanakis a nd Wirtz ,
197 9 : Na rkates and Volanaki s , 198 2) : il ) Pr evious work i n
thi s l abo ratory on thQ binding of r at CRP t o liposome s has
sho wn that the bindi ng of rat CRP t o t he liposome s i ncrCla s ed
when lysolecithin was i nco rpor ate d i nto the ph osphatidyl -
cho l i ne c ontaining liposollles (Nag pu rkar et a1. , 1983) ; iii )
The binding of hu man CRP to red blood cel ls was shown t o be
enh anced ....hen the r ed cells were treated .... ith phosphol ipase
Az or when gh os t cells ....ere used (Narkates and Vo l a na k i s,
1982); and iv) Rabbit CRP has been sho....n to deposit in
dama ged t issue du ring i nflammation (KUshner and Kaplan,
1961 ; Gitlin e t a L, , 1978; Vo l ana kis a nd Narkates, 1981;
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DuClos and Mold, 1981 ) .
B . 1M VIVO CLlARNfCI 0' RAT AS I U p CRr . RA T n p RABBIT CRP
The creae e nc e of rat asia l o CRP, r at an d rabbit CRP was
examined .1.n.....Y..1Yg and using perfused liver .
While rat a nd r abbit CRP r ema in ed in c i r cul a tion f o r
hours , Illore t h a n 50 \ of the labeled r at eeteae CRP was
remov ed from circu l at ion wi thin 4 mi n (Fig. 19) . The
c learance of labeled r at asialo CRP was i nh ibited by a slalo
AGP and a s ialo-fetuin (Fig. 20 & 21 ). but was not a f f e c t e d
by AGP (Fig . 2 1) . The se results suggest that rat asialo CRP
s h a r e s a c ommon c l e ar a nc e pathway with other asialo-
qlycoproteins.
Us i ng a live r perfusion system, it was s ho wn that t he
clearance of l ab eled r at asialo CRP by t he perfus ed l iver
wa s inhib i t ed by Ga l NAc or b y pre-treatme nt o f the l i ver
with neur aminidase (Fi g:. 27 ) . The se r e s ult s p rovide
co nc lusive ev idence that rat asialo CRP i s cle ared .in....:lh.Q
by the h e pa tic a s i aloglycoprotein r eceptor (Ashwe l l's
pathway ) •
It has been de monstrCiced that t he binding a ffin ity of
asialoglyc oprote i ns f or the asialoglycoprotein receptor
depends on the ca rb ohydrate antennary s t r uct u r e of the
g lycoproteins . The binding affinity to the hepatic a sialo-
glycoprotein receptor decreases in the o r de r of tetra- :>
tri-» bi-:> monoa ntenna ry ol i gosacchar ide cha i ns (Lee et
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a1., 1983 : Bezouska et al., 1985). The reduced binding
affinity results in slower clearance of the glycoproteins .
The carbohydrate s t r uct u r e of rat CRP has been sh own to be
biantennary (s ambas ivam at al ., 199 0), while that of AGP is
mainly triantennary . This d i f fe r e nc e i n ca r bohydra te
s t r u c t ure may e xplain the slower clearan ce rate of rat
aeLaj.c CRP compared t o that of a s Late AGP.
~ binding a s says s howe d l arge amou nts of binding
of rat as ialo CRP, r at and r abbit CRP t o the h epa tocytes
through their phosphorylchol ine binding do main (Fig. 12 &
14b) . I n t he l iver perf usion system , phosphorylcholine wa s
s h own t o have no e ffect on t h e clearanc e of rat ee t aac CRP
by the pe r fuse d liver (Fi g . 27 ) . This indicates that the
phospho r ylc holine bind i ng doma i n of rat as i a l o CRP d oes not
a f f e c t its clearance through Ashwell's pa t hway .
As a comparison to the fast clea r anc e of rat a sialo
CRP from the c i r c ul a t i on , t h e half- life o f rat CRP was
determined using five r ats (Fi'1. 19 , i n se rt) . Each point i n
t h e graph represents the da ta obta i nad from one r a t . Even
s o , the halt-life of rat CRP obta i ned i n this study is
comp arable with previously reported values (Bal t z et .a!.
1985 ) .
Afte r the c l ea ranc e of labeled r at asia l o CRP, most o f
the rad ioactive label was recovered in the liver (Fig . 22
and t able 4). However, some radioactiv e l ab el was als o fo und
in the lungs (Tab l e 4). Besides r a t asialo CRP, rat CRP and
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rabbi t CRP were found to be taken up by the lungs as well
(Fig_ 23 and Table 4). In contrast, no radioactive label
associated with AGP and asialo AGP was recovered in the
lungs. This suggests that there may be a unique relationship
between CRP and lungs.
A possible reason for the observed accumulation of CRP
in the lungs is that ether treatment might cause damage to
the lungs, and thus lead to the binding of CRP to the
damaged lung tissue. To clarify this point, some experiments
on the clearance of rat asfa Lo CRP were carried out in rats
without using lather anaesthesia. The rats were restrained at
the time of sample Inf eceten, The results obtained under
these conditions were identical to those obtained with ether
treatment. Therefore, the uptake of CRP by the lungs appears
to be a physiological event in rats.
When the clearance of labeled rat asLe j,c CRP was
competed by increasing amounts of aetate AGP (Fig. 20), the
recovery of radioactivity decreased in the liver (Fig. 24).
At the same time, there was a corresponding increase of
radioactivity associated with rat asdatc CRP in the lungs
(Fig. 24)_ The apparent connection between the clearance of
rat asial0 CRP in liver and in lungs is presently not clear.
HPLC profiles of the radioactivity associated with
liver and lungs showed that about 60-70% of the rat asialo
CRP ....a s degraded (Fig. 25) . Macrophages are abundant in
lungs, and it has been demonstrated that CRP bind to
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macrophages (Kindmark, 1972 ; Kempka ee al . , 1990 ). It i s
therefore reas onable to speculate that CRP could be taken up
and degraded by the macrophage s in the lungs . The
physiolog i cal implications of t his pos sibilit y are under
in vest i ga tion i n our l ab or atory .
A genera l scheme of t he clearance of glyc Qs ylated and
non-glyco sylated CRP by the liver an d t he l ungs is s h own i n
Fig. 28 . Pathway one (denoted by a cyc led 1) is pro pose d to
be the common c learanc e r out f or al l CRP, e i t he r
glycosyl a ted or non-gl yco sylated CRP. Pathway t ....o (d e n ot ed
by a cycl ed 2), on the othe r h and , ca n only be utili zed by
g lycosyla t ed CRP.
C. CONCLUSION wn fUTURE DIRECTIONS OF REBURCB
In c on c lus i on, r at as i a l o CRP was s hown t o b ind te t h e
hepa tic a sialoglycoprotein receptor and be clear ed in....Y..iY2
mai n l y through t his r ec eptor. The bind i ng of rat as i ale CRP ,
r at CRP and r abb i t CRP to isolated hepa t ocy te , however, was
predom ina n t l y mediated through t he i r phosp hor ylc holine
binding domain to binding s i t e s generated as a con s equen ce
of a dis ruption of the s urface of t he isolat ed hep atocytes .
Despite the l arge amount o f binding of rat asiale CRP t o the
he pa t ocy t es through the high l y conserved phosphorylcholine
binding doma in, the c l e arance of rat a s l a lo CRP via the
hepatic a sial oglyceprotein r ecep tor was not a f fect ed .
Furthermore, results from this s t u dy indicate that there
1 06
Ftc. 28, ClearaJUle tit .1'Cltlqlatll4 and tlOD-llycoll11ltll4
CRP ID Unr aAd.llU1J.
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could be an as yet to be identified pathway for the
clearance of CRP in the lungs .
Hepatocytes in diseased states have been shown to neve
altered membrane structure (Bikhazi et ""1., 1989) . Elevation
of CRP level in serum has been observed in many di.seeees
associated with inflammation or tissue destruction,
particularly in rheumatoid d.Lseasae , acute infectious
processes, postmyocardial infarct, advanced and widespread
malignancy, and acute and chronic infectiorcs (Anderson and
xccarcv, 1950 1 Stollerman et al.. 1953; Koj, 19741 Kushner
et aL, 1978b) . It has been suggested that the binding of
human CRP to the damaged membranes triggers a cascade of
illUlluno- related reactions leading Ultimately to the repair
of the damaged tissue (Kushner et aL. 1981; Volanalds and
Narkates , 1981; Robey et al., 1983) . In this context, it
would be meaningful to determine if there is a ' markedly
increased binding of CRP to diseased cells and to
characterize the binding site for CRP on cell membranes.
This may contribute to a better understanding of the
physiological functions of CRP.
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